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Abstract 
HIV protein sequence signatures for crosstalk with host proteins 
Mahdi Sarmady 
Aydin Tozeren, PhD 
 
The HIV virus targets the immune system cells and suppresses immunity.  The topology 
and connectivity of the signalling networks in host cells infected with the HIV virus are 
altered and redirected toward the synthesis of the virus.  HIV proteins interact with host 
cell DNA and proteins in modulating cell signalling and metabolic pathways. Recent 
experimental studies involving immunoprecipitation and other binding assays have 
already identified a large number of host proteins as interacting with HIV virus 
proteins. Similarly, experiments with site-directed mutagenesis and HIV protein 
segments provided information on viral sequence sites potentially responsible for 
crosstalk with host proteins.  Nevertheless, these experiments were not performed 
systematically and as a result much remains unknown about the HIV sequence hotspots 
for binding to host proteins.    
My Ph.D. thesis focuses on the identification of HIV sequence hotspots, identities of 
their target proteins hotspots are used as binding interfaces, and the identities of host 
proteins outcompeted by viral proteins in these binding interactions. For this purpose I 
use bioinformatics databases containing large numbers of copies of viral sequences, 
previously annotated HIV-host protein interactions, and the host protein interactome. 
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The large-scale datasets on sequences and interactomes are integrated with motif 
discovery, statistical enrichment, and network construction tools in a computer code to 
reveal information on the details of binding interactions between HIV and host proteins. 
This dissertation has produced a system wide portrayal of how HIV virus proteins 
interact with host hub proteins and the resulting changes in the host network. My work 
has also identified Nef sequence hotspots potentially initiating binding interactions with 
thirty or more host proteins. My findings are largely consistent with existing 
experimental data and suggest new experiments on binding interfaces as well as identify 
HIV virus sequence targets for drug discovery. In this thesis I have also illustrated the 
use of network analysis in constructing medically relevant cellular pathways such as the 
one depicting HIV virus interactions with host cell iron ion binding protein pathways. 
Taken together, my work produces bioinformatics and computational biology 
techniques specially designed to investigate crosstalk between a virus and the host.
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Chapter 1: Introduction and background 
1.1. Summary 
Our view of biological science has changed drastically in the past decade with the 
development of high-throughput technologies. Traditionally, the biological data were 
obtained through lab work, which can be costly and laborious and leads to small data 
sizes. Emerging high-throughput technologies have paved the way to the production of 
large and multi-dimensional biological datasets. Examples of these high-throughput 
technologies include next-generation sequencing [1], yeast two hybrid method for 
protein binding interactions [2, 3] and protein chips [4]. 
The biological information produced by currently available high-throughput 
technologies is limited to the determination of sequences, global gene expression profiles 
and other assays used in pharmacology. Genes and proteins can be sequenced rather 
accurately and their expression levels can be measured with minimal noise. But the 
related molecular structure datasets for interpretation of high throughput data are not 
yet comprehensive; they are limited by the pace of protein structure determining 
methods which are still far behind other biological measurement techniques. Same 
argument holds for protein-protein interactions (PPIs). Current methods of discovery of 
binding interactions between proteins do not yield insight into the details of the 
interaction sites and their structure.  These methods [3-6] indicate only that two proteins 
interact, but do not give information about structural and molecular mechanisms of the 
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interaction. Hence computational models and predictions of interaction site discovery 
can be very promising in the annotation of protein function by uncovering details of 
micromechanics of PPIs including binding sites. 
Proteins orchestrate crucial activities and functions throughout the cellular life cycle.  
The functions of proteins are typically accomplished by interactions with other 
molecules including proteins, DNA, and RNA molecules.  Interactions between proteins 
often involve formation of protein complexes [7], both in the form of transient structures 
or permanent structures. Tens of thousands of such interactions take place within a 
eukaryotic cell forming a network of interactions called the interactome [2]. 
Viral proteins alter host protein-protein interaction (PPI) networks by creating new 
interactions, modifying or destroying others. The resulting network topology favors 
excessive amounts of virus production in a stressed host cell network. Short linear 
peptide motifs common to both the virus and host provide the basis for host network 
modification [8]. A large percentage of transient PPIs occur due to the physical 
interaction of a short linear motif on one protein with a structural counter-motif on the 
partner protein [9, 10]. 
A number of recent studies focused on the identification of human proteins targeted by 
viral proteins. The list of virus-targeted host proteins is especially long in the case of the 
HIV-1 virus, arguably the most extensively studied virus at present. The motif/counter-
motif pairs involved in virus-host PPI are yet to be discovered in most cases[11]. 
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Annotation of motifs and counter-motifs on the interface of virus-host PPI will allow us 
to discover previously unknown virus-host interactions. Knowledge of the interacting 
components in virus-host PPI will impact the development of drugs that modulate or 
break bonds between virus and host proteins [12-14].  
1.2. Protein - Protein Interaction Mechanisms 
Protein functions are being carried out by its interactions with other proteins and 
molecules. Proteins participating in a PPI undergo conformation changes that facilitate 
the interaction. These structural changes may occur in a few regions of one protein 
opposing the interface with the counterpart [15]. In a recent study [16], Stein et al. 
investigated interactions of known 3D structure in the Protein Data Bank (PDB) [17] and 
showed that protein interactions can be divided into two major groups based on their 
contact interfaces: (i) Domain-domain interactions which involve the binding of two 
globular domains from different proteins which creates a large contact interface and (ii) 
Domain-peptide interactions in which a globular domain in one protein recognizes a 
short linear motif from another protein, thus making a rather small interface. Domain-
peptide interactions are mostly observed in regulatory and signaling networks, which 
involve transient binding events. It has been shown that for signaling-pathway 
regulation and cell-compartment targeting there are most likely more linear motif 
instances than there are globular domains in the proteome [18]. Transient binding 
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interactions are much more difficult to be studied using biochemical experiments [19] 
but are important in such events as phosphorylation.   
Tens of thousands of human protein-protein interactions have been reported in the 
literature.  Multiple databases exist to store these experimentally validated PPI and 
update the databases as new interactions become available. A list of the publically 
available human PPI databases is shown in Table 1. Throughout this thesis, the Human 
Protein Reference Database (HPRD; [20]) is used as the reference human PPI database 
for the studies. 
Table 1 Publically available human PPI databases details (source: [21]) 
Database Number of human PPI Number of Proteins Downlad options 
HPRD 36,617 9,427 Yes 
BIND 6,621 3,887 Yes 
DIP 1067 804 Yes 
MINT 11,367 4,975 Yes 
PDZBase 101 115 No 
MIPS 346 405 Yes 
IntAct 10244 4,614 Yes 
 
 
1.3. Linear motifs 
Linear motifs are short peptides of 3-10 amino acids length and are typically disordered 
to accommodate the more rigid interface on the opposing protein[22].  They are exposed 
to binding partners and have the ability to adapt to a variety of structural 
conformations. As mentioned in the previous section, domains in one protein recognize 
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a linear motif in their binding partner. Linear motifs involved in PPI can evolve in 
different organisms as they regularly arise and disappear by mutations hence presenting 
great adaptability to the interactome. The earliest definition of a short linear motif was 
presented by Tim Hunt in 1990 [23] : 
“The sequences of many proteins contain short, conserved motifs that are involved in recognition 
and targeting activities, often separate from other functional properties of the molecule in which 
they occur. These motifs are linear, in the sense that three-dimensional organization is not 
required to bring distant segments of the molecule together to make the recognizable unit. The 
conservation of these motifs varies: some are highly conserved while others, for example, allow 
substitutions that retain only a certain pattern of charge across the motif.” 
Linear motifs demonstrate a particular sequence pattern which contains the key residues 
that can be recognised by the binding domain [24]. These key residues can be connected 
by variable residues, which guarantee proper spacing and provide the pattern of charge 
needed across the motif. Regular expression patterns are used to describe the consensus 
patterns of the linear motifs as they are recognizable by the computer and matching 
sequences can be matched against them rapidly. A common example is the Src-
homology-3 (SH3) domain ligand. SH3 domain is shown to interact with Proline-rich 
regions of other proteins [25] . The regular expression for Class I SH3 ligand is [RK]..P..P  
[26] where `.’ denotes arbitrary (wildcard) positions and brackets denote the set of 
possible residues for the position.  
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The Eukaryotic Linear Motif (ELM) database [27] contains more than 140 patterns for 
manually curated, experimentally verified consensus patterns of linear motifs.  It uses 
regular expression in combination with logical filters to discriminate between likely true 
and false positives to improve the predictive value of the linear motifs of the database. 
The ELM database resource is the biggest database of its kind and was used throughout 
this research as the reference database of known linear motifs. 
1.4. De novo Motif Discovery 
The fact that 15- 40% of the interactions in the human proteome were estimated to be 
mediated by linear motifs [28] ,  suggests that hundreds of novel motif classes have to be 
discovered. Short length, low binding affinity, and extreme flexibility make linear motifs 
difficult for experimental analysis [8]. Emergence of proteome-scale interaction 
databases have paved the way for the development of fully computational tools for the 
discovery of de novo linear motifs associated with PPIs. 
Multiple methods and approaches have been developed for de novo motif discovery 
using protein sets and protein interactome datasets [29-34].  The main hypothesis for all 
of these tools is that proteins sharing a common attribute, such as sub-cellular location, 
biological function or a common interaction partner, would share a feature that mediates 
that common attribute. This shared feature can be either a domain or a linear motif and 
in the absence of a shared domain, a linear motif could be the only common sequence 
feature which can be revealed by virtue of over-representation [35]. 
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There are two main classes of de novo motif discovery tools: (i) Tools that discover pairs 
of correlated motifs within a set of interactions of the same type [32, 34], and (ii) Tools 
which look for over-represented linear motifs within a dataset of protein sequences with 
a common biological feature (i.e. shared interaction partner) [29, 30, 33, 35]. Discovery of 
correlated motifs on binding partners in an interactome subset reduces the discovery of 
motifs with no apparent function  [34], but is not readily suitable to the present case of 
identifying motifs on large numbers of proteins interacting with the same protein. The 
dataset that can be used in the correlated approach should be highly balanced 
(symmetric) otherwise there will be too many false negatives in the results.  
De novo motif discovery tools such as Discovery of Linear Motifs (DILIMOT) [33] are 
based on the TEIRESIAS  [36] algorithm. TEIRESIAS is an algorithm for the discovery of 
patterns in biological sequences. This algorithm can reveal all patterns (presented by 
regular expressions) that appear in at least m (a user-defined number) sequences of a 
dataset. These patterns are maximal in the sense that they cannot be made by 
concatenating other patterns and they do not have full overlaps. TEIRESIAS works 
without enumerating the entire solution space and without using pairwise alignments 
which allows for enhanced performance [36]. To reduce the rate of false positive 
discovery, motif discovery tools including DILIMOT and SLiMFinder first detect 
homologous sequences within the input dataset using BLAST [37] to determine their 
evolutionary relationship and form unrelated protein clusters (UPC) , which are defined 
such that no protein in a UPC has a relationship with any protein in another UPC [30]. 
8 
Then SLimFinder searches for motifs in all proteins and then weights results according 
to the evolutionary relationship for the proteins containing the motif. It also discovers 
patterns (motifs) with semi-conserved (wildcard) positions. 
1.5. HIV - Human Protein Interactions 
Viral proteins can interfere with host PPI networks by modifying and/or destroying the 
existent interactions or by creating new ones.  The resulting topology allows for 
increased virus production within a stressed host cell network.  The basis of these 
modifications is common short linear motifs that exist on both the viral and host 
proteins.[14, 38, 39]. As explained in the previous sections of the chapter, a relatively 
large percentage of transient PPIs are due to the physical interaction of a short linear 
motif on one protein with a structural counter-motif on the partner protein. 
A Large number of experimental studies focused on the identification of human proteins 
targeted by viral proteins. The list of virus-targeted host proteins is especially long in the 
case of the HIV-1 virus, arguably the most extensively studied virus at present. The 
motif/counter-motif pairs involved in virus-host PPI are yet to be discovered in most 
cases [39, 40]. Discovery of motifs and hotspots on HIV protein sequences at the 
interface of virus-host PPI will allow us to discover previously unknown virus-host 
interactions. Knowledge of the interacting components in virus-host PPI will impact the 
development of drugs that modulate or break bonds between virus and host proteins 
[11, 12, 14] . Currently known linear motifs are not enough to unveil the grammar of the 
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crosstalk between HIV and host targeted proteins. A recent study by Evans and 
colleagues  [40] has shown linear motifs from the ELM database [27] are poor predictors 
of interactions between HIV and human proteins and discovery of new motifs seems 
crucial. 
1.6. Significance of the Study 
This thesis mainly aims to identify the patterns present at the interface of a viral protein 
binding to a host protein. Results presented in this dissertation, will contribute a wealth 
of knowledge on HIV-1 virus-host protein interactions mediated by pairs of motifs and 
counter motifs. Computer aided rational design approaches identified a large number of 
low molecular weight inhibitors of protein-protein interactions and processes involving 
such interaction [12, 13]. One important key to success in the discovery of small 
molecules that block protein interactions has been the knowledge of the interface of 
interacting proteins. The structural coverage of protein complexes facilitates the 
discovery of small molecules for modulating protein-protein interactions [41]. The 
developments on drug design incorporating protein interactions could likely have an 
enormous impact on the treatment of viral infections. 
Despite recent progress in antiretroviral combination therapies (HAART) against HIV-1, 
drug toxicity and the emergence of drug-resistant isolates during long-term treatment of 
HIV-infected patients necessitate a new look and alternative approaches. It has been 
shown recently that a set of position-specific motifs on the sequence of HIV-1 reverse 
10 
transcriptase is strongly correlated with poor response to antiretroviral therapy [42]. In 
other words, the presence and absence of such motifs at specific regions of the HIV 
sequence is highly predictive of response to therapy. A better understanding of virus-
host proteome crosstalk may lead to the discovery of genome-wide variations in the host 
and the virus responsible for poor response to HAART therapies. Results presented in 
this thesis will provide insights on the potential use of new or existing drugs to treat 
neurological, cardiovascular and other ailments frequently observed in HIV-1 positive 
patients. One example along these lines is the use of cholesterol regulating drugs in the 
treatment of HIV-1. HIV-1 infection is known to be associated with altered lipid and 
lipoprotein metabolism and an increased risk of coronary artery disease. Bukrinsky and 
colleagues have recently shown that HIV-1 impairs ATP-binding cassette transporter A1 
(ABCA1)-dependent cholesterol efflux from human macrophages. This effect was shown 
to be mediated by Nef [43]. Therefore, discovery of motifs involved in the binding of 
HIV-1 Nef to ABCA1 could be the key for developing an effective therapy blocking 
impairment of cholesterol flux. 
The findings of the proposed research will have broad implications on viral infections of 
the human population. The motif/feature annotations developed in this study could 
potentially be applied to other virus-host interactions, such as hepatitis B and C. An 
important outcome of the proposed research will be its impact on computational 
predictions of virus-host protein interactions for viruses with available multiple 
sequence alignments. It should also be noted that the Simian Immunodeficiency Virus 
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(SIV) shares motifs with HIV-1 [44]. Findings of this thesis will have an impact in 
assessing the clinical value of experiments that utilize SIV as a model of HIV-1 such as 
those on the role of SIV Vpr on G2/M cell cycle arrest [44] as well as vaccine studies 
involving SIV [45, 46]. 
1.7. Thesis Organization 
In chapter two, sequence hotspots of HIV proteins that are associated with the crosstalk 
with host hub proteins will be discussed.   First I indentified the most important human 
protein (in terms of number of interaction partners) targeted by HIV. Then I searched for 
common patterns present on both HIV proteins and the neighbors of human proteins 
targeted by the corresponding HIV proteins. These motif patterns highlight hotspots on 
the HIV-1 proteins sequences that are crucial in the cross talkwith human proteins. 
In Chapter Three, I focused on Nef which is a regulatory HIV-1 protein and plays a 
major role in altering signaling pathways of cells. I used the same approach as in 
Chapter Two to identify hotspots on Nef associated with interactions with all human 
proteins targeted by Nef. I also studied the potential co-operation of the hotspots 
(motifs) by looking at their co-occurrence among host proteins outcompeted by Nef. 
Chapter Four, using iron dependent host cell mechanisms, illustrates how currently 
available network building techniques enable one to integrate patchy research literature 
into a portrayal of species crosstalk affecting modes of host protein networks. 
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Finally, Chapter Five concludes the thesis by summarizing the main aspects of the 
research presented in this dissertation. Next, future work that stems from this 
dissertation is discussed. I will highlight major significant achievements of this thesis 
and potential use of its results.  
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Chapter 2: HIV-1 sequence hotspots for crosstalk with host hub proteins 
2.1. Background 
Hub proteins in the human protein network undergo transient binding interactions with 
hundreds of interaction partners, as quantified in the Human Protein Reference 
Database (HPRD) [20].  Using protein-protein interaction data involving pathogen 
strains, Dyer et al. [47] illustrated the tendency of pathogen proteins to preferentially 
interact with host hub proteins.  Recent bioinformatics studies also demonstrated a 
significantly greater propensity for HIV to interact with highly connected host proteins 
[38, 48].  Multiple and repeated domains were shown to be enriched in date hub proteins 
along with long disordered regions [49], suggesting a mechanism for their ability to 
undergo transient interactions.  Pairs of strings of domains are highly predictive of hub 
protein binding to other host proteins in phosphorylation events [50], however, domain-
motif interactions appear to dominate phosphorylation of HIV proteins by host kinases 
[51].  
The HIV-1, Human Protein Interaction Database [52] identifies nineteen host hub 
proteins with at least one hundred neighbors as directly binding to one or more HIV-1 
proteins.  Some of these hub proteins phosphorylate their partners, while others cleave 
or recognize HIV protein sequences for nuclear localization. The high copy number of 
viral proteins in infected cells may lead to the out-competition of host proteins for their 
interaction with hub proteins as part of the topology of signaling and metabolic protein 
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networks [40].  To quantify the changes imposed on the host protein network by HIV, it 
would be important to identify the hotspots on HIV-1 protein sequences that are used to 
interact with hub proteins. Such hot spots could represent potential antiretroviral drug 
targets [12-14]. Moreover, sequence patterns of such spots could be used to identify host 
proteins outcompeted by viral proteins, which is in line with the concept of motif 
sharing for hijacking a host protein function [38, 39]. Viral proteins can mimic native 
interfaces and thus interfere with binding events in host protein networks [31].       
In this study, the identity of HIV targeted host hub proteins were used as the input, 
along with sequences of their binding partners and the multiple alignments of HIV 
proteins, in order to identify hotspots along the viral protein sequences for binding to 
host hubs. Motivation for this aim comes from recent system-wide studies highlighting 
the importance of HIV targeted host hub proteins in the course of infection [11, 53, 54]. 
The formula used in the present analysis for identifying sequence hotspots is based on 
motif discovery and motif enrichment.  It is well established that linear sequence motifs, 
3 to 10 amino acids long, play important roles in transient binding interactions among 
proteins [8, 55]. However, eukaryotic linear motifs documented in the literature appear 
to be too general and ubiquitous to be discriminating between false positives and false 
negatives [40, 48, 51] .  
The high throughput approach to motif discovery presented in this chapter is specific to 
HIV and host proteins. The goal is discovery of short linear protein motifs that are 
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highly statistically enriched among neighbors of host hub proteins and are highly 
conserved in the varying sequences of HIV proteins. If a motif is not highly conserved 
on known sequences of at least one HIV protein, it is likely that the motif is not essential 
to viral infectivity.  Secondly, an HIV motif involved in binding to a hub protein is likely 
to be present on the sequences of host proteins competing with HIV for transient 
binding interactions with the hub protein.  Indeed a previous study showed that this 
was the case for eukaryotic linear motifs [40].  
Multiple methods and approaches have been developed for de novo motif discovery 
using protein sets and protein interactome datasets [29-34].  Discovery of correlated 
motifs on binding partners in an interactome subset reduces the discovery of motifs with 
no apparent function  [34], but is not readily suitable to the present case of identifying 
motifs on large numbers of proteins interacting with the same hub. As in the correlated 
motif discovery approach, the approach used in this study utilizes protein-protein 
interactions, but the dataset that has been used in this study for motif discovery is highly 
asymmetric containing only nineteen hub proteins on one side and their more than a 
thousand binding partners on the other side.  
SLiMFinder [30] was employed for de novo motif discovery in this context, as it is 
comprehensive, customizable and has extensive documentation. For each HIV targeted 
hub protein, the set of host proteins that interact with the hub protein were identified 
using HPRD and sequences of HIV proteins known to bind to the hub protein  were 
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added to this list multiple. Such sequence sets containing hundreds of protein sequences 
were created for motif discovery. The resulting lists of motifs were further tested for 
their statistically enriched presence among hub neighbors in comparison to the HPRD 
proteins. Motifs that passed the test were further considered for their conserved 
expressions on hundreds of multiple alignments of HIV proteins known to interact with 
hub proteins. The approach presented in this chapter, identified discrete sets of hotspots 
on HIV protein sequences potentially involved in HIV - host hub interactions.  
Eukaryotic linear motifs that were conserved on HIV proteins and were highly enriched 
among the binding partners of hub proteins intersected with some of these hotspots. An 
extensive literature search of directed mutagenesis events showed functional validity of 
about a dozen hotspots with previously unknown motifs, indicating the biological 
context of the motif discovery presented in this study.   
2.2. Methods 
2.2.1. Data Acquisition 
Human protein interaction data were downloaded from HPRD [20], Release 8, and HIV, 
human protein interaction data were obtained from [52] (accessed December 2009). 
Eukaryotic linear motif (ELM) patterns were collected from the ELM resource [27]. The 
HIV-1 Sequence Database (http://www.HIV-1.lanl.gov/) for subtypes A, B, C, and D 
(2008 version) was used to download multiple protein alignments of HIV proteins (Env, 
Gag, Nef, Pol, Rev, Tat, Vif, Vpr and Vpu).  
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2.2.2. Dataset preparation and motif discovery 
Among the human proteins annotated as directly interacting with at least one HIV 
protein in the HIV-1, Human Protein Interaction Database, nineteen had at least 100 
immediate neighbors in the HPRD database. The choice of 100 as a lower bound for the 
number of neighbors of a hub protein is arbitrary to some extent, as some known human 
hub proteins such as CDK1 have a lower number of binding partners. Preliminary 
studies showed that the automated approach used in this chapter for motif discovery 
required significant computing time with increasing numbers of sequence batches and 
increasing numbers of sequences and lengths of sequences in each batch. The choice was 
also guided by preliminary computations indicating that no new hotspots were 
annotated on the HIV sequence as the number of hub proteins considered reached 
nineteen.  Interaction of these host proteins with HIV proteins was described in the HIV-
1 human protein interaction database, either as binding or using words such as 
‚phosphorylates‛ or ‚cleaves‛.   
In motif discovery, I sought motifs that are conserved on multiple alignments of HIV 
proteins and are over-represented among proteins that share a common function, i.e., 
interacting with the same hub protein. Thus, the sequence set for motif discovery 
associated with a specified hub protein and an HIV protein consisted of the sequences of 
all host proteins binding to the hub protein, as well as sequences of the HIV protein 
equal in number to ten percent of the number of hub neighbor sequences. The HIV 
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protein sequences used in motif discovery were chosen randomly from the collection of 
sequences. For instance, the hub protein TP53 has 266 neighbors and it is known to bind 
to Nef. Therefore, 27 randomly chosen Nef sequences were added to the dataset. 
Repeated random selection of HIV-1 sequences in this manner did not result in any new 
motif discovery.  In total, 42 datasets were created for different hub human protein 
interactions with HIV proteins.  
The sequence datasets thus prepared were fed into the motif finding tool, SLiMFinder, 
for discovery of motifs ranging from 3 to 10 amino acids in length. The Blast e-value 
used in this tool was set to 1e-28. Other parameters for motif discovery in SLiMFinder 
were set to the default values in the tool manual. Motifs computed as output were first 
matched to human proteins to eliminate abundant motifs. Motifs present in more than 
one third of HPRD proteins were filtered. A previous study based on eukaryotic liner 
motif annotation showed that motifs that were ubiquitously present were poor 
predictors of HIV- host interactions [40]. 
2.2.3. Statistical enrichment 
Statistical enrichment of discovered motifs among immediate neighbors of hub proteins 
was calculated by using the hypergeometric test against their background expression in 
HPRD. Any protein containing at least one copy of a motif was deemed as motif 
expressing. P-value cutoff of 0.005 was chosen to eliminate non-significant motifs. 
Another requirement for further annotation of the discovered motifs is their conserved 
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presence on the HIV-1 sequences. Motifs that were not present on at least 80% of all of 
the major subtypes of the corresponding HIV-1 protein sequence were removed. Since 
the approach used in this chapter is based on over representation of a motif among 
neighbors of a hub protein, only those motifs that were present on at least 20 percent of 
the neighbors of the hub protein under consideration were kept. Therefore, the final list 
of motifs for each hub-HIV-1 protein dataset contained motifs that are over represented 
and enriched among the neighbors of the hub protein, not abundant in the human 
proteome, and present on a vast majority of the sequences of HIV-1 proteins interacting 
with hub proteins. 
2.2.4. Hotspots annotation with literature on directed mutagenesis 
Discovered motifs that passed the processing described above were projected onto HIV-
1 protein sequences, and many of them contained the same sequence segments.  Such 
amino acid sequences comprised a list of hotspots. The intensity of the hotspot was 
deemed proportional to the number of hub proteins with motifs intersecting with the 
hotspot, normalized with respect to the number of hubs known to interact with the HIV-
1 protein under consideration.  Next, PUBMED abstracts were searched for directed 
mutagenesis studies involving mutations falling within the range of the identified motifs 
and hotspots. I also identified eukaryotic linear motifs that were conserved on HIV-1 
and statistically enriched among the neighbors of the hub proteins with the same cutoffs 
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used in the motif discovery. These data were used to provide a biological context to the 
HIV-1 sequence hotspots for hub protein binding in this study.   
2.3. Results  
This study aims to discover linear protein sequence motifs shared by HIV protein 
sequences and a large subset of the immediate neighbors of host hub proteins targeted 
by HIV. Randomly chosen viral protein sequences were combined with the sequences of 
proteins known to interact with HIV-1 targeted hub proteins, one hub protein at a time. 
A motif discovery algorithm was used to identify motifs that are conserved on HIV-1 
sequences and statistically enriched among neighbors of HIV-1 targeted hub proteins. 
Table 2 lists the gene IDs and gene symbols of these hub proteins, along with the 
number of immediate neighbors and the GO molecular functions of these neighbors. 
Also shown in the table are the identities of HIV proteins interacting with these hub 
proteins.  HIV-1 Tat and Nef interact with 9 and Gag with 7 of the hub proteins listed in 
Table 2. HIV-1 targeted hub proteins considered in this study are most frequently either 
kinases or transcription factors.  
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Table 2. List of host hub proteins targeted by HIV 
The table lists HIV targeted human proteins with more than 100 immediate neighbors in HPRD.  
Also listed are the numbers of neighbors of hub proteins and GO Molecular Functions enriched 
among neighbors compared to the set of HPRD proteins. The last column identifies the HIV 
proteins targeting the hub proteins. 
Entrez ID Symbol 
Neighbors 
Count 
GO Molecular Function HIV-1 Protein Interactor 
7157  TP53 266 TF, RNA binding, DNA binding Nef, Tat 
2033  EP300 210 TF activator Tat, Vpr 
6714  SRC 208 kinase, RNA binding Nef 
1387 CREBBP 198 TF activator Tat, Vpr 
5578  PRKCA 173 kinase, RNA binding Gag, Nef, Pol, Rev, Tat 
1457 SNK2A1 169 kinase, RNA binding Gag, Pol, Rev, Vpu 
5594  MAPK1 160 kinase, kinase binding, RNA binding Gag, Nef, Rev, Tat, Vif 
2534  FYN 154 kinase, RNA binding Nef 
5566 PRKACA 145 kinase, kinase binding, RNA binding Gag, Nef 
5295  PIK3R1 128 protein phosphatase binding Nef 
983  CDC2 119 kinase, RNA binding Rev 
5595  MAPK3 116 kinase, RNA binding Tat, Vif, Gag, Rev 
3725  JUN 116 TF, DNA binding Tat 
801  CALM1 114 phosphorylase kinase ENV, Gag, Nef, Pol 
7431  VIM 112 kinase binding Pol 
5970  RELA 111 kinase binding, TF Tat 
3932  LCK 105 kinase, kinase binding, RNA binding Nef 
5580  PRKCD 102 kinase, RNA binding Pol, Tat 
60  ACTB 101 kinase binding, RNA binding Gag, Pol 
 
2.3.1. HIV sequence hotspots for interaction with host hubs 
Shown in Figure 1 is a typical result of motif discovery, presented for the sets of motifs 
potentially used for crosstalk with the top 3 hub proteins and their position on HIV 
proteins. This radar plot illustrates motifs on a1) Vpr in interaction with EP300; a2) Tat 
in crosstalk with EP300; b1) Nef interacting with TP53; b2) Tat interacting with TP53; 
and c) Nef binding to SRC. The radar plot shown in the figure organizes discovered 
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motifs on circles with a radius equal to the sequence distance from the start of the 
protein sequence to the start of the discovered motif.  The figure shows that many of the 
discovered motifs that are rich in proline and related to the LIG_SH3 ELM pattern are 
spatially clustered along the sequence of the HIV protein Nef. I refrained from 
consolidating these motifs into one pattern, as the motifs shown may have slightly 
different functions, as illustrated by the multiple ELMs known to interact with SH1, 
SH2, and SH3 protein domains.  Radar plots for other hub protein-HIV protein pairs 
indicated the presence of hotspots where multiple discovered motifs merged.   
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Figure 1. Motifs for top 3 hub proteins and their position on HIV proteins  
This radar plot illustrates the HIV protein motifs discovered in the present study. a1) Vpr motifs 
for crosstalk with EP300 a2) Tat motifs for crosstalk with EP300, b1) Nef motifs for TP53, b2) Tat 
motifs for P53; and c) Nef for SRC motifs.  More Detail on each motif is available in additional 
files. Sequence positions are mapped to distance from the radius. The dark edge represents the 
start of the motif and the lighter edge represents the end of the motif. 
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Next, the motifs that we discovered on the neighbors of multiple hub proteins were 
plotted on the HIV protein sequence, and the amino acids along the HIV protein 
sequence were marked with grayscale intensities proportional to the number of hubs 
associated with a motif on the hotspot. The resulting sequence hotspots for HIV proteins 
Tat, Rev, Nef, Gag, and Pol are shown in Figure 2. For achieving simplicity in the figure, 
only those hotspots with motifs from at least two hubs have been shown along the HIV 
proteins (horizontal axis) for hundreds of sequences ranging from 637 for Tat to 1792 for 
Gag. The figure shows increasing entropy on hotspot positions with increasing sequence 
length and sequence copy number.  Aligning sequences for optimizing positional 
conservation required too many gap insertions and thereby distorted the actual 
positions of these motifs on the majority of the sequences for a given HIV-1 protein and 
thus this route was avoided. The figure shows four hotspots on Tat, five on Rev, eight on 
Nef, and significantly more on Gag and Pol.  
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Figure 2. Motif hotspot positions on HIV protein sequences 
Amino acid sequence positions of motif hotspots are shown on the horizontal axis. Color 
intensity is proportional to the number of hub proteins with enriched hotspot motifs among its 
immediate neighbors. Regions highlighted in this figure have at least two different hub proteins 
associated with them. 
Next, I considered whether the hotspots shown in Figure 2 were mainly due to host hub 
proteins having large numbers of commonly shared neighbors. The heat map indicating 
the number of common neighbors for pairs of HIV targeted hubs is shown in Figure 3. 
Hotspots containing motifs from at least three hub proteins do not have enough 
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common neighbors to overcome the minimum 20% presence limit among hub neighbors 
imposed on motifs discussed in the present study. Similarly, hotspots composed of 
motifs from two hubs share few common neighbors, except in cases between MAPK1 
and MAPK3, and also between EP300 and CREBBP.  The hotspot shown in between 
position 2 to 7 on Rev is indeed due to MAPK1 and MAPK3 having common neighbors. 
However, this is a rare event among the hotspots shown in Figure 2  or the motif sets 
presented in Appendix 1.  
 
Figure 3. Heat map for common s among hub proteins considered in the study 
The number of common immediate neighbors between two hub proteins is shown in the form of 
a square matrix.  Color intensity is proportional to the number of protein neighbors common to 
two hub proteins. 
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2.3.2. Biological context for sequence hotspots 
An important subset of the motifs presented in Appendix 1 corresponds to motifs 
already annotated by the ELM web server. Shown in Table 3 are the ELMs that satisfy 
the three conditions imposed on motif discovery, namely these ELMs are conserved 
along the HIV protein sequence, expressed infrequently on HPRD proteins, and are 
highly statistically enriched among the neighbors of hub proteins. The start and end 
positions of ELMs on HIV protein sequences is also shown in the table. The ELM motif 
LIG_SH3, a kinase associated motif, is present on HIV proteins Env, Gag, and Nef, 
whereas the nuclear localization signal motif TRG_NLS_MonoCore_2 is found on Tat 
and Pol. The PCSK cleavage site is found to be conserved on Rev and Pol. The 
immunoreceptor tyrosine-based switch motif is found expressed by Env.  The fact that 
the method presented in this chapter, reproduced all eukaryotic motifs satisfying all 
stringent criteria (as explained in previous sections of the chapter) for motif annotation 
provides support against an extensive presence of false negatives in the motif discovery 
approach of this study. 
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Table 3. Eukaryotic linear motifs (ELMs) present on HIV and enriched among neighbors of 
hub proteins  
The Start and End points of ELMs are specified based on the most commonly observed start and 
end points on the HIV protein sequences. The p-values listed stand for the statistical enrichment of 
the ELM among neighbors of the hub protein using a hypergeometric test. 
HIV ELM Name Start End Hub Entrez ID Hub Gene Symbol p-value 
Env 
MOD_TYR_ITSM 35 43 801 CALM1 9.80E-04 
LIG_SH3_4 117 125 801 CALM1 5.30E-04 
Gag 
LIG_SH3_2 288 294 
1457 CSNK2A1 2.79E-03 
5578 PRKCA 1.73E-03 
5594 MAPK1 1.92E-04 
5595 MAPK3 4.33E-04 
LIG_SH3_1 451 458 5594 MAPK1 4.24E-04 
Nef LIG_SH3_2 72 78 
2534 FYN 2.67E-06 
5295 PIK3R1 6.08E-06 
5578 PRKCA 1.73E-03 
5594 MAPK1 1.92E-04 
6714 SRC 2.18E-11 
Pol 
 
CLV_PCSK_PC7_1 233 240 801 CALM1 7.79E-04 
TRG_NLS_MonoCore_2 255 261 1457 CSNK2A1 2.99E-03 
Rev CLV_PCSK_FUR_1 39 44 1457 CSNK2A1 4.01E-03 
Tat 
 
TRG_NLS_MonoCore_2 48 54 
2033 EP300 2.99E-05 
3725 JUN 1.28E-03 
5970 RELA 1.18E-03 
7157 TP53 5.78E-04 
1387 CREBBP 1.88E-05 
Vif LIG_SH3_1 158 165 5594 MAPK1 4.24E-04 
 
Next, a literature search was conducted on directed mutagenesis of HIV sequences and 
focused on 24 research articles presenting HIV mutations that intersect with the motifs 
discovered in this study. Fourteen of these mutations came with functional changes in 
HIV-host interactions as detailed in Table 3.  For example, the hotspot positioned at 
residues 15-19 of Tat contained mutation S16A that is known to prevent Tat 
phosphorylation. The hub protein interacting with Tat at this position is PRKCD, a 
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kinase known to phosphorylate Tat.  The second set of mutations (R52Q, R53Q) fell onto 
the hotspot intersecting with TRG_NLS_MonoCore ELMs, a motif recognized by the 
importer protein importin-alpha. The sequence hotspots on HIV proteins Vif, Vpr, and 
Vpu are not shown in Figure 3 for brevity, since there is no hotspot with more than one 
associated hub protein; however some of the discovered motifs on these proteins 
(presented in Appendix 1) intersect with mutations known to affect viral protein 
activity (Table 4).   
HIV protein regions binding to some of the hubs shown in Table 2 were previously 
identified in the literature.  Shown in Table 5 are twelve such regions that intersect with 
the hotspots shown in Figure 2 and another five that do not match with the hotspots. 
The approach of this study, discovered hotspots at the binding sites of Tat with CREBBP 
and EP300, but missed the Gag binding site to ACTB, and Rev to CDC2. One of the 
mismatches was due to the stringent criteria set for defining hotspots. The site of Vpu 
binding to CSNK2A1 was correctly recovered using the motif with regular expression 
[AGS]..S..E.[DE] in the sequence position 49 to 58 (Appendix 1) but this site was not 
shown in Figure 2 because it involved just one hub protein instead of two or more 
designations that was used for the definition of a hotspot. 
30 
Table 4. HIV amino acid mutations found in research literature within the range of motifs 
annotated in this study  
The result of the literature search for the studied mutations on HIV-1 proteins that occur in the 
region of the discovered motifs is presented in this table. The related paper is listed in the Pubmed 
ID column. The mutation under consideration is presented in the Mutation column. Motif Pattern 
is the regular expression of the motif to which the mutation corresponds. Start and End of the 
motifs are specified based on the most commonly observed start and end on the HIV protein 
sequences. 
HIV-1 Pubmed ID Mutation Motif Pattern Hub Symbol Start End Phenotype 
Gag 9420228 [56] P222A 
A.{0,1}G.{0,2}P.{1,2}P CSNK2A1 217 223 
Diminishes virion incorporation of CyPA 
and interfere with HIV-1 replication 
P..PG MAPK3 219 224 
Nef 
10547288 [57] 
 
F90R 
[DE]L..[FIL][IL] MAPK1 87 93 
Reduces the affinity of SH3 binding 
(specifically in HCK, similarly in FYN, 
LCK) 
[DE]L..[FL]L LCK 87 93 
F.{0,2}L.{0,2}K FYN 91 94 
10489340 [58] R77A P..P.R 
PIK3R1, SRC, 
MAPK1 
73 79 
Decreases downregulation of class I 
MHC 
Pol 20450778 [59] 
K101P K.K.I PRKCD 98 103 
Correlated with drug resistance (failing 
combinational antiretroviral therapy) 
K219 A..KK ACTB 215 220 
K70R [KR][ILV]..Q.[KR] CALM1 68 75 
Tat 
8709193 [60] R52Q, R53Q 
KR..R RELA 51 56 
Repeals Tat binding to TAR element 
and gene trasactivation 
[AS]..R.[KR][KR] JUN 46 53 
[KR][KR][KR][KR] EP300, CREBBP 49 53 
17083724 [61] S16A [FHY]..[ST].P PRKCD 13 19 
Prevents Tat phosphorylation and 
interferes with activation of HIV-1 
provirus 
Vif 8626571 [62] S144A S.Q.L MAPK3 144 149 Loss of Vif activity (not phosphorylated) 
Vpr 
14506268 [63]  I61A,L64P E.[IL].[KR].[LV] EP300 57 64 Enhances pro-apoptotic activity of Vpr 
9557700 [64] Q65E QQL CREBBP 65 68 Impairs Vpr nuclear localization 
Vpu 20078884 [65] S52A [AGS]..S..E.[DE] CSNK2A1 50 59 
Interrupts phosphorylation of Vpu 
required for degradation of tetherin 
 
Next, the hotspots were mapped to the 3D structures of three of the smaller HIV 
proteins under consideration. Tat, Rev, and Nef were retrieved from the protein data 
bank (PDB) [17],  and hotspots on these structures were highlighted in orange in 
Figure 5. Note that structures in PDB are not complete and do not include the entire 
31 
sequences for Rev and Nef. Nevertheless, the figures clearly show that the identified 
hotspots do not form conformational recognition features.  More likely, they are being 
utilized in anchoring two proteins at multiple sites. Motif combination sets used in 
binding events could be potentially quantified to some extent by statistical enrichment 
of their co-occurrence among the neighbors of the hub proteins targeted by HIV and not 
considered in this study. 
 
 
Figure 4. Hotspots on HIV protein structures 
Hotspot regions highlighted in orange on Tat (a), Rev (b), and Nef (c) proteins. PDB structures 
1TBC [66] , 2X7L [67], and 2NEF [68]were used respectively. Numbers on the structures reflect 
the start and stop positions on the actual HIV protein sequence. Molecular graphics images were 
produced using the UCSF Chimera package [69] 
2.4. Discussion  
The HIV alters the host cell macromolecule network and redirects cellular processes 
towards the synthesis of new viral particles. Binding interactions of HIV proteins with 
host proteins, DNA and RNA constitute a fundamental mechanism in the modification 
of host cellular networks in favor of viral production. Network connectivity is 
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significantly affected by the binding of viral proteins to host hub proteins. As shown in 
Table2, nineteen such host proteins with at least 100 binding partners appear as directly 
interacting with HIV proteins in the HIV-1 Human Protein Interaction Database. HIV-
targeted host hub proteins are typically protein kinases and/or transcription factors. 
Therefore, alterations in their connectivity directly impacts signal flow through 
pathways and potentially leads to significant changes in global gene expression profiles.  
Given that an HIV protein binds to a host hub protein, what can be said about the 
altered connectivity of the hub protein? One scenario would be that binding of the HIV 
protein to the hub protein occurs at sites utilized by host proteins to bind to the hub. 
Examples of such sites include phosphorylation and docking sites [51]. Even if 
phosphorylation of an HIV protein turns out to have little functional consequence on its 
own, the fact that multiple host proteins are outcompeted by the thousands of copies of 
the HIV protein would implicate a strong impact on network connectivity on the hub 
node under consideration.  This is the rationale for the focus of the present study on the 
grammar of interactions between HIV and host hub proteins.  
This study presents sets of newly annotated hotspots on HIV virus proteins as potential 
sites for binding to host hub proteins. The hotspots are at the intersection of short linear 
motifs shared by HIV proteins and the host proteins outcompeted by HIV proteins. A de 
novo motif discovery algorithm [30] was used with sequence data as the input, consisting 
of a hybrid of HIV-1 and host protein sequences, as described in methods. The output 
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consisted of motifs shared by the HIV and the host proteins competing in binding events 
to host hub proteins. As such, my computationally intensive motif discovery process 
used 42 sequence sets containing from a minimum of 111 to a maximum of 293 protein 
sequences. The motifs discovered in this study are (i) conserved on HIV protein 
sequences, (ii) found in less than one-third of the host proteins, and (iii) are statistically 
enriched among neighbors of host hubs targeted by HIV proteins. The sequence 
positions of these motifs on the HIV proteins constitute potential binding sites for host 
hubs.  Thus, through a convoluted bioinformatics approach requiring extensive data on 
protein sequences and interactomes, the interface between HIV and host hub proteins 
was estimated. 
The presented computational estimates of hotspots along the sequence of HIV proteins 
identified eukaryotic linear motifs associated with a nuclear localization signal on Tat 
and Pol, a PCSK mediated cleavage site on Rev and Pol, and a proline-rich kinase 
substrate motif on Env, Gag, and Nef (Table 3). In fact, this method reproduced all the 
eukaryotic linear motifs satisfying the stringent criteria imposed on their expression on 
HIV and on the neighbors of hub proteins. Findings of this study are also in line with 
large-scale experimental data on directed mutagenesis of the HIV sequences.  Fourteen 
phenotype-altering single residue changes of HIV proteins collected from the literature 
were mapped onto the hotspot locations (Table 4). Additionally, the predictions of this 
study recaptured a large majority of the known interfaces between HIV and hub 
proteins (Table 5). To my knowledge, the large-scale motif analysis presented in this 
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study constitutes the first comprehensive map predictive of HIV-host hub binding 
interfaces. It was possible to create a hotspot map for the HIV proteome thanks to the 
extensive research findings in the literature on the identity of host hub proteins 
interacting with HIV proteins.   
Potential uses of HIV sequence hotspots depicted in this study range from drug 
development to a better understanding of the mutation phenotypes in their linkage to 
host protein networks. Rational drug design procedures are increasingly focusing on 
developing drugs targeting protein-protein interaction interfaces [12]. The data 
produced by this study shows that the specific motif sequence segments expressed by 
viral proteins are often different than the motif sequences commonly used by the host.  
This provides an opportunity to block the binding interactions of HIV proteins and the 
host hubs using peptides or small molecules, without affecting hub connectivity to other 
host proteins.  Another potential use is to provide a biological context for mutation 
phenotypes that maybe expressed in general terms, such as loss of viral infectivity [88].  
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Table 5. Available literature information on the binding sites of hubs and HIV-1 proteins 
binding interactions 
Information available in the literature on the binding sites of the interaction between hub 
proteins and HIV-1 proteins is listed in the table. Description is the information available in the 
paper regarding the interaction site. Pubmed ID refers to the paper from which binding 
information was collected.  
HIV-1 Hub Entrez ID Hub Symbol Description Pubmed ID 
ENV 801 CALM1 768 to 788 and 826 to 854 of gp41 8226798 [70] 
GAG 
60 ACTB 10 and 11 12009869 [71] 
5578 PRKCA 111 8473314 [72] 
NEF 
 
801 CALM1 1 to 20 (n-terminal) 15632291 [73] 
2534 FYN 65 to 82 7859737 [74] 
3932 LCK 69 to 78 8794306 [75] 
5295 PIK3R1 c-Terminal 12009866 [76] 
5566 PRKACA 6 to 9 15629779 [77] 
5578 PRKCA nef 15 9049329 [78] 
5594 MAPK1 69 to 78 8794306 [75] 
6714 SRC Proline-rich domain 16849330 [79] 
7157 TP53 1 to 57 (n-terminal) 11861836 [80] 
REV 
983 CDC2 14 
8806671 [81] 
1457 CSNK2A1 5 to 8 
TAT 
1387 CREBBP 1 to 24 12549909  [82] 
2033 EP300 48 to 57 11080476 [83] 
5578 PRKCA 46 
8914829 [84] 
5580 PRKCD 46 
VIF 
5594 MAPK1 96 and 165 
9792705 [85] 
5595 MAPK3 96 and 165 
VPR 2033 EP300 64 to 84 12208951 [86] 
VPU 1457 CSNK2A1 52 to 56 8548340 [87] 
 
Hotspots link a phenotype altering mutation on an HIV protein to the identity of the 
host protein it interacts with at the site of mutation, allowing the use of bioinformatics in 
outlining a protein network pathway responsible for the phenotype.  The motif 
collection presented in Appendix 1 is a comprehensive list of protein motifs shared by 
host hub neighbors potentially outcompeted by HIV.  The size of the hub neighbor 
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protein set expressing a given motif provides a first order approximation of the identity 
of hub neighbors potentially outcompeted by HIV. A recently obtained crystal structure 
of HIV-1 Tat complexed with human P-TEFb provides further evidence that viral and 
host proteins interact on multiple sites, even in such rapid interaction events such as 
phosphorylation [89]. One could further refine the predicted outcompeted protein set by 
identifying those hub neighbor subsets enriched with an expression of multiple motifs 
positioned at different hotspots along the viral protein.  
The motif sets presented in this study could be refined further by future bioinformatics 
studies utilizing structural information.  Consideration of motifs within the context of a 
structural organization of proteins, such as their presence on helical loops [90] and 
disordered regions [91], may lead to a better understanding of the grammar of the HIV 
virus - host protein interactions and the role of short linear motifs in these interactions.  
Additionally, correlated motif approaches detailed in the literature [34]  provide a map 
for identifying the interface on the hub protein interacting with a hotspot on the viral 
protein.  Protein-protein interactions studied in this work for hotspot generation were 
asymmetric in the form of a single hub interacting with hundreds of proteins.  The 
asymmetric sequence data used in this chapter were not suitable for a high throughput 
correlated motif approach.  Now that HIV sequence hotspots are annotated with the 
motifs potentially used in binding to hub proteins, the recipe presented by Tan et al. [34] 
still provides a valuable opportunity to identify hub protein interfaces at hotspots. This 
study presents the first viral sequence hotspot map for the interaction of viral proteins 
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with the host hub proteins.  The map is for the HIV proteome, the only viral proteome 
where extensive data exists concerning its communication with the host proteome. The 
hotspots on the viral protein sequences are potential binding sites to host hubs. Motifs 
that define the hotspots are indicators of the identities of host proteins outcompeted by 
viral proteins in their interactions with host hubs. The map presented in the study is 
highly consistent with experimental findings mined from the literature via text 
searching algorithms and subsequent manual curation.  Findings of this study, impact 
well on drug development focusing on binding sites.  Such findings will advance the 
knowledge regarding the details of the crosstalk between a virus and its host.  
2.5. Conclusions 
This study presents the first viral sequence hotspot map for the interaction of viral 
proteins with the host hub proteins.  The map is for the HIV proteome, the only viral 
proteome where extensive data exists concerning its communication with the host 
proteome. The hotspots on the viral protein sequences are potential binding sites to host 
hubs. Motifs that define the hotspots are indicators of the identities of host proteins 
outcompeted by viral proteins in their interactions with host hubs. The map presented in 
the study is highly consistent with experimental findings mined from the literature via 
text searching algorithms and subsequent manual curation.  The findings impact well on 
drug development focusing on binding sites. Such findings will advance our knowledge 
regarding the details of the crosstalk between a virus and its host.   
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Chapter 3: HIV Nef motifs for crosstalk with host proteins 
3.1. Background 
Viruses utilize host cellular mechanisms to redirect cell machinery toward viral 
replication.  The process of viral replication includes multiple steps such as the 
incorporation of viral genome into host DNA, the synthesis of viral proteins using host 
machinery, and the assembly of viral particles. Viral proteins transiently and selectively 
bind to the DNA, RNA and the proteins of the host [92, 93] . The identification of host 
proteins targeted by viral proteins is important in outlining the progression of the 
infection and the key targets of the infection for developing virus- and patient-specific 
therapies and vaccine development.   
Considering the fact that new viruses emerge in numbers and that advanced eukaryotes 
possess tens of thousands of proteins, identifying virus-host protein interactions in a 
wholesale manner is out of the question with the present experimental approaches. Such 
procedures combine multiple methods including co-immunoprecipitation, yeast two 
hybrid, protein arrays, phosphorylation assays, directed mutagenesis and others. 
Moreover, data generated from existing methods is noisy and the level of noise increases 
with generic, large-scale applications of such methods [94].  
Recognizing the need for the discovery of the grammar used in virus-host interactions, a 
number of recent studies utilized machine learning algorithms, association methods, 
39 
and statistical enrichment to predict virus host protein interactions [40, 48, 51]. These 
studies annotated the viral sequences host motifs and domains previously associated 
with binding interactions in the host proteome. The short linear motifs are typically 
relatively disordered and flexible segments of proteins and as such may be involved in 
protein-protein interactions with more ordered molecular recognition features (MoRFs) 
on opposing proteins [22] . Molecular recognition features may be composed of amino 
acid residues not necessarily adjacent in sequence and could be parts of the closely 
packed regions of proteins called domains [95]. Because viral proteins are relatively 
flexible and contain long disordered segments, they may potentially express motifs 
targeting host proteins [38, 39].  
A single motif-domain pairing may not be enough for inducing functional binding 
interactions; multiple bridges and interfaces are observed in 3D configurations of 
protein pairs [10].  Moreover, short linear motifs documented in open access 
bioinformatics databases such as the Eukaryotic Linear Motif (ELM) database [27] 
present regular expressions of over 140 motifs, expressed by eukaryotes.  Prediction of 
PPI with currently annotated motif-domain pairings result in statistically significant 
intersections with experimental data [40, 48]. However, the presence of large numbers of 
false positives and false negatives in this approach creates a challenge in evaluating the 
directional changes in signal flow in host protein networks caused by the virus.  It 
appears that data on viral sequence and host interactome may not be sufficient at the 
present to decipher the grammar of the crosstalk between viral and host proteins.  
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Recent advances in motif discovery on protein sets could be translated into the 
discovery of motifs specific to virus host interactions. Viral protein sequences of 
retroviruses such as HIV is highly variable but collection of such sequences alone is not 
sufficient for motif discovery since such an attempt typically yields thousands of motifs 
consisting of sequences with low entropy. In the previous chapter, a scheme was 
proposed for viral protein motif discovery using data on the binding interactions of 
virus host proteins. In this scenario viruses hijack the function of host proteins by 
outcompeting them in binding to other host proteins. It is assumed that viral proteins 
use motifs to interact with the interfaces on host proteins used for binding to other host 
proteins [14, 39, 44, 74].  Therefore motif discovery is carried out on protein sets 
composed of host proteins potentially outcompeted by viral proteins. Host protein set 
composed of all binding partners of host proteins targeted by the virus are enriched 
with outcompeted host proteins and as such comprise a set for motif discovery.  Adding 
random samples of viral protein sequences assures that at least a significant subset of 
motifs discovered exist on the viral sequence as well as a subset of outcompeted 
proteins.   
Protein features on the human proteome are better documented than viral proteomes in 
general. A number of open access web tools are available to annotate human proteins 
with motif regular expressions and protein domains [27, 32, 96, 97]. Moreover, recent 
bioinformatics studies have already associated pairs of protein signatures on opposing 
proteins to protein-protein interaction events [32]. In this study, the aforementioned 
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bioinformatics tools were used to make advances toward deciphering the grammar of 
HIV Nef-host protein interactions.  
HIV Nef is a regulatory viral protein present in primate lentiviruses. It has a strong 
impact on the optimal replication of the virus, playing a major role in the transcription 
and translation of viral proteins. The Nef-protein is expressed abundantly in the early 
stages of viral replication [98, 99]. It possesses a structurally flexible N-terminal 
membrane anchor region of 60 residues, followed by a well-conserved and folded C-
terminal core domain of about 130 residues. A flexible loop, 30 amino acids long, 
projects out of the core domain. Nef is post-translationally modified by phosphorylation 
and by the irreversible attachment of myristic acid to its N-terminus [98, 99] . 
One of the main functions of Nef in viral replication is altering the signaling pathways of 
cells by interacting with tyrosine and serine/threonine kinases [77]. Nef increases the 
infectivity of the virus after entry into the cell [100]. Its interaction with the components 
of endocytic machinery decreases the expression of CD4 and major histocompatibility 
complex class I (MHC I) antigens on the surface of infected cells [101]. The molecular 
mechanism of Nef-mediated downregulation of CD4 and MHC I molecules are 
relatively well understood, but correlating these functions with the pathogenesis of 
AIDS is not straightforward [102]. Downregulation of CD4 may be important for 
optimal virus replication and it may facilitate the release of virions. Molecules that block 
the main interaction sites of Nef could be useful therapeutic agents [99] . 
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The HIV-1, Human Protein Interaction Database (HHPID) [52] identifies more than 
nineteen human proteins targeted by Nef. The immediate neighbors of the Nef targeted 
host proteins can be identified to an extent using existing human protein interactome 
databases such as HPRD [20]. Moreover, in much of these interactions, experimental 
data is available either on motifs involved or the sequence positions of the interface 
between Nef and host proteins, allowing for a critical assessment of the proposed system 
approach.  The results show high consistency with experimental data and provide 
insights into motif combinations used by viral proteins in targeting host proteins.  
3.2. Methods 
3.2.1. Data Acquisition 
Human protein interaction data were downloaded from the Human Protein Reference 
Database (HPRD) [1], Release 8. The HIV, Human Protein Interaction Database (HHPID) 
[8] (accessed December 2009) was used to obtain HIV Nef – host protein interactome. 
Host proteins targeted by HIV Nef were identified as those that are listed in HHPID as 
directly binding to or co-localized with Nef. In addition, the research literature linked to 
HHPID was screened to prepare summary tables of experimental data concerning motifs 
and sequence segments involved in host - Nef protein interaction events. These tables 
were then used to assess the overall consistency of the results with the research 
literature.  The HIV-1 Sequence Database (http://www.HIV-1.lanl.gov/) for subtypes A, 
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B, C, and D (2008 version) was used to download multiple protein alignments of the 
HIV protein Nef.   
Human protein sequences from NCBI’s GenBank were screened for annotation of 
protein domains using PROSITE (version 20.31) [97]. Similarly, the Eukaryotic linear 
motif (ELM) resource was used to annotate protein sequences ELMs. The same set of 
sequences was screened for motifs discovered in the present study using regular 
expressions of the motifs.   
3.2.2. Dataset preparation 
In this study, 42 human proteins in HHPID were identified as participating in binding, 
phosphorylation, and cleavage interactions with HIV Nef. All three of the chosen 
interaction types involve direct binding of Nef to human proteins. Nineteen out of the 
forty-two had at least twenty direct partners (Table 6). These proteins were scanned 
against PROSITE [97] domain patterns and results are depicted in Figure 6. In total, 27 
different domains are present on the list of 19 human proteins targeted by Nef. Among 
these domains, six are either signatures of kinases or Src homology profile which is in 
line with the fact that Nef is getting phosphorylated within the cell to alter major 
signaling pathways of the cell. No PROSITE domain was observed on AP2B1 and 
GNAO1.  
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Table 6. Human Proteins Targeted by Nef with interactions involving protein binding 
entrez ID gene Symbol Neighbors entrez ID gene Symbol Neighbors 
7157 TP53 266 1315 COPB1 17 
6714 SRC 208 162 AP1B1 17 
5594 MAPK1 160 164 AP1G1 17 
2534 FYN 154 8726 EED 17 
5295 PIK3R1 128 3107 HLA-C 14 
801 CALM1 114 3106 HLA-B 14 
3932 LCK 105 5478 PPIA 13 
5894 RAF1 93 3135 HLA-G 10 
7409 VAV1 62 55690 PACS1 10 
10399 GNB2L1 59 2625 GATA3 8 
3055 HCK 56 8943 AP3D1 8 
5062 PAK2 42 10318 TNIP1 8 
375 ARF1 39 3133 HLA-E 7 
4217 MAP3K5 38 8906 AP1G2 6 
920 CD4 33 942 CD86 5 
2775 GNAO1 33 3134 HLA-F 5 
163 AP2B1 32 1174 AP1S1 5 
3105 HLA-A 22 941 CD80 4 
8907 AP1M1 21 8905 AP1S2 3 
10015 PDCD6IP 19 51606 ATP6V1H 2 
2623 GATA1 18 5692 PSMB4 2 
 
 
In this chapter, the nineteen proteins (H1 proteins) were focused on for motif discovery 
as the approach presented in this chapter works best for sets of proteins with large 
amounts of binding partners. In motif discovery, each H1 protein was considered 
separately and sought motifs that are over-represented among its neighbors (H2 
proteins). These H2 proteins share a common property which is interaction with the H1 
protein. In addition to H2 proteins, Nef interacts with the H1 protein and the goal was to 
discover motifs common between Nef and H2 proteins. As a result, Nef sequences were 
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added to the dataset of H2 sequences. Nef sequences were selected randomly and their 
number was proportional (10%) to the number of H2 sequences in the dataset under 
consideration. Repeated random selection of Nef sequences in this manner did not result 
in any new motif discovery. In total, 19 datasets were created for the discovery of motifs 
potentially involved in the binding interactions of Nef and its host protein partners.  
 
Figure 5. PROSITE domain annotations for top 19 human protein targeted by nef 
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The sequence datasets thus prepared were fed into the motif finding tool, SLiMFinder, 
for discovery of motifs ranging from 3 to 10 amino acids in length. The Blast e-value 
used in this tool was set to 1e-28. Other parameters for motif discovery in SLiMFinder 
were set to the default values in the tool manual. Motifs computed as output were first 
matched to human proteins to eliminate abundant motifs. Motifs present in more than 
one third of HPRD proteins were filtered. A previous study based on eukaryotic liner 
motif annotation showed that motifs that were ubiquitously present were poor 
predictors of HIV- host interactions [40] . 
3.2.3. Statistical enrichment 
The statistical enrichment (over-representation) of the discovered motifs was calculated 
among immediate neighbors of hub proteins by using the hypergeometric test against 
their background expression in HPRD. Any protein containing at least one copy of a 
motif was deemed as motif expressing. A p-value cutoff of 0.001 was used to eliminate 
potentially insignificant motifs. Another requirement for further annotation of the 
discovered motifs is their conserved presence on the HIV Nef sequences. Motifs that 
were not present on at least 80% of all of the subtypes of the Nef protein sequences were 
removed. Therefore, the final list of motifs contained motifs that are over represented 
among the neighbors of Nef targeted proteins, not abundant in the human proteome, 
and present on a vast majority of the sequences of HIV Nef proteins in the sequence 
database. 
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3.2.4. HIV Nef sequence hotspots for crosstalk with host proteins 
The H2 motifs that passed the processing described above were projected onto HIV Nef 
protein sequences. Many of these motifs partially overlapped on the sequence.  These 
motifs were clustered automatically based on their location on the Nef sequence. The 
developed clustering algorithm is an iterative merging algorithm. At the beginning each 
motif is considered as a cluster. Two clusters are merged if the sum of the mismatch 
between their beginning and ending positions (on Nef) is less than six amino acids. 
Merging was done iteratively through the motif list until no cluster changed. Each such 
cluster was labeled by the start and the end of the region on Nef covered by the cluster.  
These clusters represent hotspots on Nef. Each hotspot corresponded to a subset of H1 
proteins for which a motif belonging to the hotspot was enriched among the immediate 
neighbors of these H1 proteins. Thus the subsets of H1 proteins potentially interacting 
with Nef via the hotspot were identified by this study.  
Next, for each H1 protein interacting with a hotspot, the subsets of H2 proteins were 
identified by requiring the members of the subsets to express at least one motif clustered 
on the hotspot. The subsets of H2 proteins thus computed provided lists of host proteins 
potentially outcompeted by HIV Nef as a function of the hotspots expressed by Nef. 
Gene ontology molecular function level four was determined as a function of Nef 
hotspots for both and H2 proteins potentially outcompeted by Nef.  
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3.3. Results 
The motif discovery approach used in this chapter computes Nef sequence motifs 
potentially targeting host proteins in an indirect fashion: I actually conduct motif 
discovery on the sequences of host proteins neighboring Nef targeted host proteins. The 
hypothesis is that Nef copycats motifs on host proteins used in their binding 
interactions. Since Nef is relatively flexible and disordered compared to host proteins in 
general, it is feasible that a disordered short linear segment of Nef binds to an already 
established interface position on a host protein. Small numbers of Nef sequences were 
added into the set of sequences used in the motif discovery to assure that some of the 
output motifs are expressed by the majority of Nef sequence collections used for 
verification. The host proteins targeted by HIV Nef were identified from HHPID and are 
shown in Table 7 along with the gene symbols/names for these proteins, and 
information the on number of host protein neighbors these proteins have. The table 
shows 19 of the Nef-targeted host proteins as having at least twenty immediate 
neighbors ranging from 266 neighbors for TP53, 208 for SRC and 160 for MAPK1 to 20 
for AP1M1.  For each of these nineteen proteins, the motif discovery tool was run and 
determined a set of motifs statistically enriched on H2 proteins of the given H1 as well 
as expressed by at least 80 percent of the multiple alignments of HIV Nef in the 
collection of Nef sequences.  Because there is a significant range difference in the 
numbers of direct neighbors of Nef-targeted host proteins, an additional restriction was 
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added which is the motif discovered must be statistically enriched within the set of H2 
proteins for all nineteen H1 proteins compared to host proteins in HPRD.   
The results indicate multiple hotspots on Nef for interacting with the host proteins. 
Table 7 shows the HIV Nef short linear motifs that passed the aforementioned criteria.  
The table presents the regular expression (patterns) of such motifs along with their start 
and end points along the Nef sequence.  Also shown in the table are the identities of H1 
proteins for which the motif is statistically enriched on the set of its binding partners. 
Additionally, for each hotspot, statistically enriched GO molecular functions (level 4) of 
human proteins expressing any of the motifs in the cluster were computed and added to 
Table 7. Overall, there are ninety such patterns and some are enriched among the 
neighbors of multiple H1 proteins. These motifs were clustered according to their 
sequence position on Nef, resulting in 20 such clusters, with the largest one containing 
the proline-rich motifs spanning Nef residue positions 69 to 81. Next in abundance are 
the leucine-rich motifs in the sequence region from residue 85 to residue 96. The twenty 
clusters thus formed create hotspots on HIV Nef for potential binding interactions with 
host proteins (Figure 7).
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Table 7. Motif Clusters (hotspots) on Nef 
The table lists the motifs enriched among the immediate neighbors of human proteins targeted by Nef. These motifs are clustered based on their 
start and end on the Nef sequence. The ELM columns corresponds to the most similar ELM to the motif pattern. GO_MF4is a list of top GO 
molecular level 4 annotations for the human proteins containing the corresponding motif. 
cluster motif start end associated h1s ELM GO_MF4 
1_8 [IMV]..K.[GS][HK] 1 8 AP1M1 - 
adenyl nucleotide binding, purine 
ribonucleotide binding, kinase  
13_19 W.{1,2}A.{0,2}E 13 19 VAV1 - 
phosphotransferase, kinase, adenyl 
nucleotide binding 
26_35 [AS]..[GS]..[AGS].S 26 35 AP1M1 LIG_WH1 
transcription factor ,  adenyl nucleotide 
binding, kinase  
31_37 [GS][AS].[ST].[DE] 31 37 CD4 - 
transcription factor , kinase , adenyl 
nucleotide binding 
37_42 L.K.G 37 42 TP53 - 
adenyl nucleotid binding, purine 
ribonucleotide binding, kinase  
44_48 [ST][ST].N 44 48 FYN - 
purine ribonucleotide binding, transcription 
factor , kinase  
66_72 
[DE][LV][GS]F 66 70 PAK2 - purine ribonucleotide binding, adenyl 
nucleotide binding, kinase  [DE].[GS][FH].[LV] 66 72 AP1M1 - 
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Table 7. (continued) 
cluster motif start end associated h1s ELM GO_MF4 
69_85 
F.[FILV]..Q 69 75 PAK2 - 
Kinase , phosphotransferase , purine 
ribonucleotide binding 
[FV]..[KR]P.[IV] 69 76 AP1M1 - 
P..P..P[FILV] 70 78 HCK LIG_SH3_1 
P.{0,2}P.{0,2}P.{0,2}P 70 80 MAPK1, FYN, HCK, LCK, SRC, PIK3R1 LIG_SH3_1 
V.P..P 71 77 ARF1 LIG_SH3_1 
[HKR]P..P 72 77 FYN, VAV1, SRC LIG_SH3_1 
P.VP 73 77 FYN, HCK, VAV1 LIG_SH3_1 
P..P.[HKR] 73 79 FYN, VAV1 LIG_SH3_2 
P..P.R 73 79 
MAPK1, FYN, HCK, VAV1, SRC, 
PIK3R1 
LIG_SH3_2 
Q.P.[HKR] 74 79 FYN - 
Q.P..P 74 80 PAK2, FYN, HCK, LCK, SRC LIG_GYF 
PL.P 75 79 ARF1 LIG_GYF 
[FLV]P..P.T 75 82 HLA-A LIG_SH3_1 
P.[KR]P 76 80 VAV1 LIG_SH3_1 
P.[HKR]P 76 80 VAV1 LIG_SH3_2 
L.P.T 76 81 GNB2L1 - 
P[LMV].P.[ST] 76 82 HCK LIG_SH3_1 
P..P.T 76 82 PAK2, FYN, HCK, HLA-A LIG_SH3_1 
P..P.[ST]..[AG] 76 85 HLA-A LIG_SH3_1 
P..P.[ST]..[AGS] 76 85 MAPK1, CALM1 LIG_SH3_1 
80_92 
[LM][ST][FY]..[AG]..[FIL] 80 89 PAK2 - guanyl-nucleotide exchange factor, 
SH3/SH2 adaptor, small GTPase regulator [HK]..[FLV].L..[FY] 83 92 ARF1 - 
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Table 7. (continued) 
cluster motif start end associated h1s ELM GO_MF4 
85_96 
[AS]..[FL]..[FLM]..E 85 95 MAP3K5 LIG_BRCT_BRCA1_1 
purine ribonucleotide binding, kinase , 
phosphotransferase  
[DE]L[GS][FH] 87 91 PAK2 - 
[DE]..[FHY][FY] 87 92 FYN LIG_WH1 
[DE]L..[FL]L 87 93 LCK TRG_LysEnd_APsAcLL_1 
D..[FH][FL][LV] 87 93 HCK TRG_LysEnd_APsAcLL_1 
[DE]L..[FIL][IL] 87 93 MAPK1 TRG_LysEnd_APsAcLL_1 
[DE][ILM]..[FIL]..E 87 95 RAF1 - 
L..FL 88 93 HLA-A - 
L..[FIL]L[KR] 88 94 VAV1 LIG_NRBOX 
[FIL]..[FI][IL]..[KR] 88 96 HLA-A - 
[FIL]..F[IL]..[KR] 88 96 HLA-A - 
[IL]..[FY]L..[HKR] 88 96 ARF1 MOD_TYR_DYR 
[GS].[FIL][LV]K 89 94 ARF1 - 
[FH]FL..[KR] 90 96 HLA-A - 
90_102 
[FHY]..K.[KR]..[FLV] 90 99 MAP3K5 LIG_MAPK_1 
adenyl ribonucleotide binding, protein 
kinase , pyrophosphatase 
F.{0,2}L.{0,2}K 91 94 FYN - 
F.KE 91 95 ARF1 - 
FL..K 91 96 HLA-A, VAV1 - 
[FWY]..E..G..G 91 101 PAK2 - 
L..K.G 92 98 AP2B1 - 
[GS].L[DE].[FL] 96 102 AP1M1 - 
108_113 
Q.{1,2}I.{0,2}D 108 113 ARF1 - 
adenyl nucleotide binding, purine 
ribonucleotide binding, kinase  
[DE][ILMV][LV][DE] 109 113 AP2B1 - 
I.{0,2}L.{0,2}D 110 113 VAV1 - 
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Table 7. (continued)      
cluster motif start end associated h1s ELM GO_MF4 
111_117 
[LV].[IL][WY].Y 111 117 PAK2 - phosphotransferase, kinsae , purine 
ribonucleotide binding [DE].[FWY].[FY] 112 117 RAF1 - 
118_126 
Q.{0,2}F.{0,1}D 118 124 AP2B1 - 
metal ion binding, adenyl nucleotide 
binding, purine ribonucleotide binding 
QG.[FILV]P 119 124 PAK2 - 
Q..[FY].D 119 125 AP1M1 - 
Q..[FWY]..[FWY] 119 126 CALM1 - 
Q..[FHY]..[FWY] 119 126 CALM1 - 
[GS][FY][FI]P 120 124 AP1M1 - 
G[FWY][FIV]P 120 124 PAK2 - 
G[FY][FI]P 120 124 PAK2 - 
121_132 
[FY]..[DE][FWY] 121 126 MAP3K5 - 
purine ribonucleotide binding, adenyl 
nucleotide binding, kinase  
[FHY]..[DE]..N 121 128 AP2B1 - 
P..Q.[FY] 123 129 GNB2L1 - 
[DE].Q.[FWY] 124 129 FYN LIG_CAP-Gly_1 
[DE]..N.[ST] 124 130 FYN, LCK - 
[FWY].N.[ST] 125 130 CD4 LIG_SH2_GRB2 
W.{0,2}Y.{1,2}G 125 132 CD4 - 
N[FHY][ST] 127 130 GNB2L1 - 
130_138 
P.P..[HKR] 130 136 FYN, HCK LIG_GYF 
phosphotransferase, transcription factor, 
kinase  
P.P..[HKR].P 130 138 HCK - 
P..[HKR].P 132 138 MAPK1, FYN - 
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Table 7. (continued) 
cluster motif start end associated h1s ELM GO_MF4 
136_141 
[FY]P..[FHY] 136 141 AP1M1, PAK2 - 
protein domain specific binding, enzyme 
binding, purine nucleotide binding 
[FY]P..[FY] 136 141 AP1M1 - 
[FWY]P..[FY] 136 141 LCK - 
139_145 
T.{0,2}F.{0,1}W 139 143 GNAO1 - phosphotransferase , kinase , ion 
transmembrane transporter [FW][GS]..[FWY] 140 145 MAP3K5 - 
160_169 
EN..L 160 165 TP53 - peptide receptor, adenyl nucleotide 
binding, transmembrane receptor N..[IL].P 163 169 HLA-A - 
200_206 
[FHY]P..[FY] 200 205 PAK2 - 
Kinase , phosphotransferase , purine 
ribonucleotide binding 
PE.{0,1}Y 201 204 HLA-A - 
[DE][FY][FWY] 202 205 AP2B1, RAF1 - 
[DE][FWY][FY] 202 205 AP1M1 - 
[DE][FY][FY] 202 205 AP2B1, RAF1 - 
[FWY][FY][HK] 203 206 VAV1 LIG_WH1 
55 
 The majority but not all of the 1689 sequences in the multiple alignment of Nef express 
the motifs shown in Figure 7 within the twenty aforementioned hotspot positions.  
Shown in Figure 9 are the motif clusters on Nef along the 3D crystal structure. The start 
position of the hotspots is marked on the 3D structure. It is known that Nef core regions 
have multiple configurations depending on the myristylation of its N terminal region  
[103]. All the interactions mediated by the regions highlighted in the figure cannot 
happen simultaneously, because the binding sites are overlapping. It is probable, that 
different interactions occur at different stages of the viral life cycle. Nef may have a 
closed conformation, where the unsaturated parts are protected, and an open 
conformation, where the interaction sites are at hand. 
 
Figure 6. Motifs presence on Nef sequences 
Amino acid sequence positions of motif hotspots are shown on the horizontal axis. Color 
intensity is proportional to the number of Nef targeted proteins with enriched hotspot motifs 
among their immediate neighbors. 
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The results indicate the presence of multiple binding sites on Nef for the host proteins it 
targets. Shown in Figure 8 are the hotspots linked to Nef targeted host proteins. The 
links in blue indicate computational predictions of this study with no experimental 
verification whereas those in purple indicate similar predictions with experimental 
support from directed mutagenesis and other methods as listed in HHPID. The figure 
shows that the developed bioinformatics approach correctly recaptures the functional 
role of the proline-rich Nef hotspot in binding to FYN, GNB2L1, HCK, MAPK1, PK3R1, 
SRC, and VAV1.  Statistical method assessment of the match is not suitable in the 
current state of meager and noisy data on Nef – host protein binding interface sites. 
Nevertheless, the present findings bring a rationale for design of the high throughput 
experiments for elucidating information on HIV virus host protein interaction sites.  
Next the lists of host proteins potentially outcompeted by Nef at the hotspots were 
determined and depicted in Figure 7.  For this purpose, the immediate neighbors of the 
hotspot interacting H1 proteins expressing a motif falling onto the hotspot were 
identified.  DAVID bioinformatics tools  [104] was used to annotate the gene ontology 
molecular function assignments of these proteins as shown in Table 7. Some of the 
motifs in the twenty clusters on Nef hotspots have patterns that intersect the previously 
annotated eukaryotic linear motifs presented in the ELM web tool.  A case in point is the 
proline-rich motif described by the regular expression P..P.  Also shown in Table 7 are 
the ELM motifs deemed similar to the motifs on the hotspots using the CompariMotif 
[105].  
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Figure 7.  Hotspots and their corresponding H1 proteins 
Columns indicate hotspots on Nef named by their start and end position on Nef. Rows represent 
gene symbols of Nef H1 proteins. An H1 protein associated with a hotspot is indicated by blue 
color in the corresponding box. Purple boxes are the hotspots and h1s which their interaction is 
validated in the literature. Pink boxes are hotspots that their interaction with the corresponding 
H1 protein is validated in the literature but the motif’s matching the hotspot are not enriched in 
the neighbors of the H1 protein. 
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Figure 8. Motif Clusters highlighted on Nef 3D crystal structure 
Regions covered by clusters of motifs highlighted in orange on Nef. PDB structure 2NEF [68] was 
used. Numbers on the structures reflect the start positions of the clusters. Molecular graphics 
images were produced using the UCSF Chimera package [69]. 
3.4. Discussion 
In the absence of antiretroviral therapy, HIV infection causes progressive loss in CD4 
lymphocyte numbers and function, resulting in the immunodeficiency associated with 
AIDS. Recently, HIV Nef has been shown to be the main determinant of accelerated CD4 
lymphocyte depletion in vivo [106, 107]. HIV Nef is a 25- to 30-kDa myristoylated 
protein which is produced in the early stages of an infection [108]. In infected cells Nef 
localizes at the plasma membrane and preferentially associates with the cytoskeleton, 
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but it is also found at the nuclear membrane, in the cytoplasm, and in the nucleus [109-
112]. HIV Nef has been shown to down-regulate cell surface CD4 and major 
histocompatibility complex class 1 molecules, augment virus infectivity, and to 
modulate multiple cellular signaling pathways in both CD4 lymphocytes and 
macrophages [113]. Nuclear localization of Nef in HIV-infected cells suggests a 
functional role as a nuclear regulatory factor. 
Nef regulation of T-cell activation and associated pathways involves direct binding 
events between Nef and cellular signal transduction elements such as CD4, NAK, Raf-1, 
MAPK, and p53 as quantified using coprecipitation, enzyme-linked immunosorbent 
assay and other binding assays [114]. Similar binding assays with Nef fragments provide 
information about the sequence location of binding sites between Nef and host proteins  
[80].  For example such experiments led to the observation that HIV Nef binding to TP53 
protected cells against p53-mediated apoptosis and that N terminal region of the protein 
up to residue 57 was responsible for binding [80]. 
Site-directed mutagenesis of HIV proteins and synthetic peptides from conserved 
regions of Nef were used to identify Nef residues crucial for binding to host HLA-A3.1 
[115]. The amino acid at position 152 of the A3.1 molecule appeared to be critical for this 
binding event. Other site-directed mutagenesis experiments revealed the importance of 
Nef residues 55 to 58 in binding to CD4 [116]. Similar experiments presented evidence 
that a diacidic motif on Nef and the basic patch on alpha-adaptin are both required for 
the cooperative assembly of a CD4-Nef-AP-2 complex [80]. The research literature on 
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Nef binding to host proteins compiled in the HHPID database was reviewed which 
brought out an incomplete and perhaps a noisy portrayal of the motifs and interfaces 
associated with the binding of Nef to host proteins. 
Lack of a high throughput binding assay for identifying Nef motifs responsible for 
binding to host proteins prompted me to explore the use of extensive genomics and 
proteomics data in a motif discovery approach to extract knowledge on Nef binding 
motifs targeting host proteins. Within relatively disordered regions of proteins lie short 
linear peptide sections that are responsible for thousands of protein–protein interactions 
[117]. Specific examples of motifs binding to protein domains such as the SH3 and WW 
domains are listed in the ELM database [27]. Peptide mediated interactions are typically 
transient, and occur particularly in signaling pathways [118]. The fact that Nef is 
relatively flexible and disordered and that it undergoes a cascade of transient 
interactions with the host provides strong rationale for the computational discovery of 
Nef peptides undergoing binding interactions with host proteins.  
Although the principles of motif discovery were already established in the literature [29, 
30, 32-36] and there are multiple open-access motif discovery tools that exist for short 
linear protein motifs, actual application to this case proved extremely challenging. First 
motif discovery was performed for nineteen Nef-targeted host proteins, one at a time 
using sets of sequences of proteins binding to the targeted host protein. This approach 
resulted in large numbers of motifs with no peptide instances conserved on more than a 
thousand Nef sequences available in the literature.  Adding too many sequences of Nef 
61 
to the set of sequences for motif discovery overwhelmed the computations with peptides 
specific to Nef only. The optimal combination was settled to adding Nef sequences to 
each set at a one-to-ten ratio.  Still, the output of any run of motif discovery resulted in 
annotation of thousands of motifs on the Nef sequence, merely over 200 residues long. 
Therefore, I focused only on those motifs that were relatively conserved on HIV Nef 
sequences, were infrequent in the host proteome but highly abundant on the binding 
partners of the host protein targeted by Nef.  
Results showed multiple motifs projecting onto similar regions of the Nef sequence. For 
example, proline-rich motifs most frequently projected on Nef residues 69-96. Another 
hotspot was formed between residues 118 and 132. Overall, nearly half of the residues of 
Nef fell onto a motif discovered in this analysis. A hotspot is a sequence segment 
intersected by multiple motifs. The motifs were clustered based on where they fell on 
the Nef sequence, with the same start residue for each motif in a cluster. Clusters often 
intersected at the same hotspot. Next, motif similarity approaches were used to identify 
in some cases the ELM motifs with matching sequences satisfying both motif regular 
expressions.  Such ELM motifs shown in Table 7 were comprised of phosphorylation site 
motifs for kinase substrates as well as motifs known to be used in binding to host 
protein domains. Comparison with known motifs presents the possibility of a functional 
annotation of the motif prior to experimental verification.   
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The results show multiple Nef hotspots for a host protein to bind to. Many of the motifs 
annotated in this study will likely lead to the small interfaces between Nef and its 
protein partners.  This may result in the affinity of the interactions being weaker than 
that for typical interactions between globular domains with larger interfaces. 
Nevertheless multiple such interactions could be optimal for transient binding modes 
between kinases and substrates where pairs of proteins must be docked before 
phosphorylation occurs.  How do we know which combination of Nef hotspots 
comprise a plausible set of binding interfaces to a given Nef targeted protein? To 
address this question, Nef motifs potentially targeting a given host protein were 
determined. Then we the binding partners of the host protein carrying the motifs under 
consideration were identified. The combination with the largest number of common 
outcompeted proteins is likely to comprise the interface of Nef with a host protein. 
Results shown in Table 8 require further validation.   In this table, each row lists a triplet 
of clusters. Clusters of this triplet co-occur more than any other possible triplets for the 
associated Nef targeted protein (H1).  Occurrences of the clusters among the neighbors 
of the H1 protein (Nef targeted) under consideration were calculated. For a given H1 
protein and a triplet of three clusters, the last column is a probabilistic score calculated 
using the following formula: 
𝐶𝑜 − 𝑜𝑐𝑐𝑢𝑟𝑟𝑒𝑛𝑐𝑒 𝑆𝑐𝑜𝑟𝑒 =  
𝐶123
𝐶1𝐶2𝐶3
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Where C123 is the number of neighbors of H1 protein that contain all three clusters. C1, C2, 
C3 are the number of neighbors of H1 that contain the first, second and third clusters 
respectively. This score represents a relative likelihood of co-occurrence of the clusters in 
the triplet in comparison with random. For MAPK1, HCK, FYN which are all kinases, 
three clusters of 69 to 85, 74 to 85, and 130 to 138 occur together which suggest that not 
only the proline rich region of Nef (69 to 85) is important for Nef to get phosphorylated 
by kinases, but also another region stretching from residue 130 through 138 also 
potentially plays a role in the phosphorylation process. 
Table 8. Co-occring clusters on Nef and outcompterd proteins 
The table lists triplets of co-occuring clusters among the clusters discovered in this chapter. 
Cluster counts represent number of times a cluster was observed mong the neighbors of the 
protein associated with the cluster. Score is the relative likelihood of co-occurrence as explained 
in the text. 
Nef 
Target Cluster1 
Cluster1 
Count Cluster2 
Cluster2 
Count Cluster 3 
Cluster 3 
Count 
All 3 
clusters Score 
PAK2 136_141 1556 69_85 2621 200_206 1642 461 6.16 
MAPK1 69_85 2465 130_138 2375 74_85 1119 403 5.51 
HCK 69_85 3717 130_138 2737 74_85 2587 1113 3.78 
MAP3K5 85_96 1003 139_145 2474 121_132 2464 174 2.55 
FYN 69_85 4926 130_138 3870 74_85 3237 1703 2.47 
AP2B1 118_126 1987 200_206 2781 108_113 2688 403 2.43 
AP1M1 90_102 1267 200_206 2785 26_35 2439 224 2.33 
HLA-A 163_169 1339 85_96 2736 74_85 1812 172 2.32 
VAV1 69_85 4363 74_85 2676 108_113 2746 721 2.01 
LCK 136_141 1339 69_85 2422 121_132 2434 177 2.01 
ARF1 69_85 2860 85_96 2234 108_113 2400 340 1.98 
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These computations of Nef hotspots comprising binding interfaces with host proteins 
have implications in drug discovery. The small sizes of the interacting surfaces 
comprised by the motif and its counterpart makes them better candidates for 
intervention by small molecules than larger domain–domain interfaces [6,7]. Indeed, 
there are already potential drugs that inhibit protein–peptide binding.  The cancer drug 
candidate compound Nutilin-3 disrupts the p53-MDM2 complex by mimicking a 
peptide in P53, one of the Nef targeted proteins. The drug is thought to free P53 to 
respond to DNA damage [8,9]. The research presented here could potentially identify 
therapeutic uses for a number of existing drugs and drugs in clinical trials   
The approach taken can only uncover those Nef motifs that are also being used by host 
proteins to bind to interfaces on the 3D structures of host proteins, in this case, mostly 
kinases, transcription factors, and G proteins.  If a motif is specific to a viral protein and 
is not part of the vocabulary of the host proteome, the approach of this study will likely 
not detect it correctly.  
3.5. Conclusions 
In this chapter, Motifs and hotspots on Nef that are associated with the binding to 
nineteen human proteins targeted by Nef were identified. Additionally, these hotspots 
were annotated with associated Nef targeted proteins.  Co-operation of motifs for 
binding were studied by calculating co-occurrence frequencies of all of the motif clusters 
to identify triplets of clusters with more likelihood of co-occurence. These findings can 
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guide further experiments to establish the role of new binding sites which ultimately can 
lead to the discovery of new PPI-blocking methods in particular for HIV Nef. 
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Chapter 4: Connectivity Map of Iron-binding Proteins in HIV infection 
4.1. Background 
Metal ions play fundamental roles in switching proteins to active states in all living 
beings. The redox abilities of ferrous (Fe2+) and ferric (Fe3+) iron are essential for 
eukaryotic biological systems [119].  In mammals, iron in hemoglobin and myoglobin 
binds oxygen allowing for its transport to cells in the vicinity of blood vessels.  In 
addition, iron acts as a cofactor for enzymes involved in energy metabolism 
(mitochondrial respiratory chain and Kreb’s cycle) and DNA synthesis, rendering it 
essential for cells [120, 121].  Moreover, iron has a crucial role in immunity and 
immunosurveillance through involvement in cell-mediated immune effector pathways 
and cytokine activities.  Iron promotes the growth of immune cells [120, 122, 123], 
thereby affecting the immune response to an invading pathogen.  In return, cytokines 
and radicals produced and released by the immune cells control and regulate iron 
homeostasis via transcriptional and post-transcriptional methods [120].  Hence, iron 
metabolism and the immune system possess a delicate relationship through which they 
can regulate one another. 
While iron is important for mammalian cells and deficiencies result in aberrant cell 
proliferation and immune function, iron overload can be deleterious [119, 120], affecting 
the proliferation and activation of T-cells, B-cells and natural killer cells [120, 124, 125].  
One mechanism through which iron loading can affect cells is by inhibiting IFNG-
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mediated pathways in macrophages, which causes them to lose their ability to kill 
intracellular pathogens [120].  Moreover, the lack of an iron excretory pathway in 
mamallian cells highlights the importance of homeostatic mechanisms adopted by cells 
in order to balance out iron needs as opposed to iron overload as well as redox utility as 
opposed to resulting toxicity.   
The initial step for achieving homeostasis is through the regulation of iron absorption 
from the gut.  However the process of transporting iron to usage and storage sites is 
equally important, in addition to the roles of enterocytes and macrophages [119].  
Monocytes and macrophages utilize different pathways to obtain iron.  These methods 
include transferrin-mediated uptake, transmembrane uptake of ferrous and ferric iron, 
obtaining iron through lactoferrin or ferritin receptors, as well as through 
erythrophagocytosis.  As a result, the proliferation and differentiation of these cells are 
not affected by limiting the iron supply through one of these sources [120]. 
 
Iron-binding proteins often appear in the lists of proteins targeted by infectious agents. 
For example, many of the activities of the host cells targeted by HIV are iron-dependent 
[126]. Viruses depend on host cells for their survival and viral replication requires 
enhanced cellular metabolism for transcribing and translating viral genomes and 
proteins.  Since these processes depend on and require iron, the host cells have to 
contain a sufficient supply of iron to meet the demands [121].  Iron accumulation can 
accompany the more advanced stages of HIV infection [126, 127], while increased iron 
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storage in bone marrow macrophages could be associated with shorter survival times 
[128, 129].  Elevated iron stores have been detected in other tissues of HIV patients 
including brain, liver and muscles [126].  In this study, public databases and 
bioinformatics tools were used to develop a connectivity map for HIV and host proteins 
in iron ion mediated signaling and metabolism. The resulting map is a portrayal of what 
is known about the iron ion mediated cell pathways targeted by HIV.   
4.2. Methods 
4.2.1. Identification of iron-associated proteins 
To determine the human proteins that are associated with iron binding, a list of relevant 
Gene Ontology [130] molecular function categories were obtained. List of proteins 
annotated with GO molecular function iron ion binding were retrieved from the GO 
Consortium [130] and DAVID Bioinformatics [104]. For each category the two protein 
list were compared and those found only in DAVID were checked against the literature 
and UniProtKB [131] database to confirm their functional association with iron. Proteins 
with literature support were merged to produce a final list for each category. Only genes 
with RefSeq status of ‚REVIEWED‛ or ‚VALIDATED‛ were retained; in this process 18 
genes were eliminated. 
 
In addition to the proteins annotated with the aforementioned GO categories, 6 others 
were added to the list of iron-associated proteins based on a review paper by 
Drakesmith and Prientice on iron metabolism and viral infection [121]. GLRX2 was 
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among the iron binding proteins and GLRX5 which is a protein from the same family is 
annotated with iron-sulfur cluster binding were added to the list as well. ERCC2 is an 
iron-sulfur complex binding protein which is part of a complex that binds TAT and is 
part of the HIV-1 transcription regulatory process therefore it was added to the list. The 
final list contained 299 proteins associated with iron. 
4.2.2. Pathway visualization 
A list of proteins interacting with HIV-1 proteins was obtained from the NIAID HIV-1, 
Human Protein Interaction Database [52] (Version: December 2009) containing 1433 
different human proteins with 68 types of interactions (e.g. binds, activates, upregulates, 
downregulates, etc.). The overlap between this list and the list of iron associated proteins 
resulted in 40 proteins associated with 99 different interactions with 12 HIV-1 proteins. 
CYP27B1 was the only protein whose interaction with the HIV-1 matrix protein was 
ambiguous and did not fit any of the pathway notations so it was removed from the 
pathway. CellDesigner  [132] was used to visualize these interactions between the HIV-1 
proteins and the human iron-associated proteins in a pathway based on interaction 
types and intracellular locations of the proteins involved. For each interaction an 
extensive PubMed search was conducted to determine type, intracellular location and 
conditions under which the interactions take place. These literature searches allowed for 
the addition of other essential human proteins associated with the main interactions in 
the pathway. PubMed IDs of relevant papers of each interaction were added as notes to 
provide quick access through CellDesigner. SMBL notation available in CellDesigner 
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was adapted to visualize these interactions and make changes when needed. The list of 
notations and symbols used in the pathway is shown in Figure 10. 
4.3. Results and Discussion 
A total of 313 proteins were identified to be iron-associated with the use of gene 
ontology categories. Out of 313 proteins, the iron binding motif [DE]..E is present on 289 
of them. However, the motif is ubiquitously present on the human proteome; 30466 out 
of 38829 NCBI human proteins express the motif. Therefore, the presence of the motif in 
its current form was not used to further restrict the subset of host iron-binding proteins. 
Among the host iron-binding proteins, 40 appeared in the HIV-1, Human Protein 
Interaction Database (HHPID) as a subset of the 1393 host proteins targeted by HIV 
(Table 9). A hypergreometric test was used to calculate the significance of the overlap 
using all human proteins from NCBI as the background.  The p-value was found to be 
1.8e-12, indicating a high-level of statistical enrichment of iron-associated proteins 
among known HIV-1 interacting host proteins. Iron binding host proteins targeted by 
HIV populate different modes of crosstalk with virus proteins as shown in Table 9.  Iron-
binding proteins appear more often in HHPID as ‘upregulated’ and ‘stimulated by’ than 
in direct ‘binding’ interactions.  The reason these proteins may appear more affected by 
HIV infection than the rest of the human protein pool is because they are more centrally 
connected in the protein network as assessed by estimation of their binding partners in 
the human protein network. Nevertheless, a system view, as adopted here, may help 
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construct links among the research results concerning different regions of the 
connectivity map developed in this study.  
The connectivity map shown in Figure 10 presents a network scale of interactions of HIV 
proteins with iron binding proteins of the host. The map uses a notation described in 
Figure 11 that identifies the modes of interaction. The map also includes host proteins 
neither interacting with iron ions nor with HIV but have central connectivity roles in the 
map. In the paragraphs below the important loci of the connectivity map are 
highlighted. These proteins are not necessarily among the ones directly interacting with 
HIV proteins but are centrally connected in the map.  
Table 9. Human Iron binding proteins- HIV-1 interactions  
Types of interactions between HIV-1 proteins and iron-associated proteins  
SYMBOL Gene ID Interaction Type HIV 
ABCE1 6059 associates with PR55 
    associates with VIF 
ALOX5 240 upregulated by GP120 
APP 351 activated by RETROPEPSIN 
    inhibited by GP41 
    inhibits GP120 
    inhibits TAT 
    upregulated by TAT 
CAT 847 inhibits GP160 
CYBB 1536 inhibited by CASPID 
CYC1 1537 release induced by VPR 
CYCS 54205 released by VPR 
CYP51A1 1595 upregulated by NEF 
DOCK2 1794 associates with NEF 
GLRX2 51022 activates RETROPEPSIN 
GLRX5 51218 activates RETROPEPSIN 
HFE 3077 downregulated by NEF 
HMOX2 3163 upregulated by GP120 
IDO1 3620 release induced by GP120 
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Table 9. (continued) 
SYMBOL Gene ID Interaction Type HIV 
IKK1 1147 binds GP120 
    phosphorylated by NEF 
IKK2 3551 binds GP120 
    phosphorylated by NEF 
IKKE 9641 binds GP120 
    phosphorylated by NEF 
LTF 4057 inhibits GP120 
NOS1 4842 inhibited by TAT 
    upregulated by GP41 
NOS2 4843 inhibited by TAT 
    upregulated by GP120 
    upregulated by gp41 
NOS3 4846 inhibited by TAT 
    upregulated by gp41 
NOX1 27035 activated by GP120 
NOX3 50508 activated by GP120 
NOX4 50507 activated by GP120 
NOX5 79400 activated by GP120 
PPP1CA 5499 downregulated by GP120 
    stimulates TAT 
PPP1CB 5500 stimulates TAT 
    upregulated by GP120 
PPP1CC 5501 stimulates TAT 
PPP2CA 5515 inhibits TAT 
PPP2CB 5516 inhibits TAT 
PPP3CA 5530 activated by TAT 
PPP3CB 5532 activated by TAT 
PPP3CC 5533 activated by TAT 
PTGS1 5742 upregulated by GP120 
    upregulated by TAT 
PTGS2 5743 upregulated by GP120 
    upregulated by TAT 
SDHB 6390 binds TAT 
TFRC 7037 downregulated by GP120 
    downregulated by NEF 
TH 7054 downregulated by TAT 
 
NADPH-Oxidase: NADPH oxidase is an enzymatic complex composed of multiple 
proteins. Iron is essential for the functioning of the NADPH oxidase complex with a 
heme-b acting as the prosthetic redox group in cytochrome b.  Iron deficiencies therefore 
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result in reduced enzyme activity [133]. NADPH oxidase is the main producer of 
superoxide anion (O2-) through the reduction of oxygen.  In the cell, superoxide 
dismutase (SOD) then acts as an antioxidant by utilizing electrons from copper or zinc 
for the conversion of superoxide into hydrogen peroxide (H2O2).  In resting cells, the 
NADPH oxidase complex is typically dormant.  Monocytes and macrophages usually 
release increased levels of reactive oxygen species (ROS) as a response to certain stimuli.  
The generation of high levels of ROS, referred to as a respiratory burst, plays an 
important role in the host defense mechanism against pathogens [134, 135]. These 
reactive species are therefore involved in inflammatory processes, apoptosis, aging and 
carcinogenesis [136].   
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Figure 9. Pathway of interactions between iron binding proteins and HIV-1 proteins 
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Figure 10. Pathway Notations  
Legend showing different notations used in the pathway 
HIV-1 targets NADPH oxidase indirectly, through other proteins.  First, gp120 binds to 
CXC chemokine receptor 4 (CXCR4) which in turn activates the NAPDH oxidase 
complex resulting in increased expression of superoxide radicals and subsequent 
activation of neutral sphingomyelinase, inducing apoptosis and cell death [137].  On the 
other hand Nef plays a time-dependent role in this process.  In the early stages, Nef is 
responsible for the induction of phosphorylation and cell-membrane translocation of 
NCF1 and NCF2, hence activating NADPH oxidase, which results in the production of 
superoxide [134, 135]. Meanwhile, gp160 also enhances the respiratory burst and 
oxidative stress through the production of H2O2 [136].  Within 10 hours however, Nef 
inhibits NADPH oxidase resulting in a dysregulation in the production of ROS, 
impairing specific immune functions including the oxidative burst response and 
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phagocytosis.  This in turn allows for the development of HIV-1 pathogenesis [134, 135].  
In addition, the viral capsid has been shown to inhibit the interferon-gamma (IFN-) 
induced accumulation of the cytochrome B heavy chain mRNA, which is a component of 
the NADPH oxidase complex [138]. 
HuHP68 (ABCE1) Complex: While the HIV protein Vif is excluded from the mature viral 
particles, it is essential for viral infectivity.  It is therefore a late HIV-1 product, acting in 
the latter stages of the virus life cycle during viral assembly and/or maturation to 
enhance the infectivity of the progeny virions [139, 140].   Vif interacts with cellular 
ABCE1 and viral PR55 (Gag) to assist in capsid assembly.  ABCE1 is known to function 
as an RNAse L inhibitor, suggesting that the viral association with ABCE1 is possibly to 
protect the viral RNA from degradation during viral assembly [139].  HIV-1 Gag 
polypeptides are synthesized in the cytoplasm of infected cells and then are trafficked to 
the plasma membrane.  ABCE1 is then recruited to sites of assembling Gag at the 
membrane and the association continues throughout capsid formation until the onset of 
viral maturation and its subsequent release [141]. Typically ABCE1 is required for 
cellular survival, mRNA translation, and ribosome biogenesis.  It is the only ATP-
binding cassette enzyme that has an amino-terminal iron-sulfur cluster domain, thus 
necessitating the availability of iron for its functioning [121, 142]. 
 
In addition to ABCE1, PR55 also recruits the ESCRT (endosomal sorting complex 
required for transport) pathway protein VPS23 (TSG101) from the ESCRT-I complex as 
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well as PDCD6IP which interacts with ESCRT-I and CHMP4 (from ESCRT-III) proteins 
[143, 144].  ESCRT proteins are usually involved in the sorting of ubiquinated proteins 
including ligand-activated cell surface receptors in order to deliver them into the lumens 
of multivesicular bodies.  VPS23 typically results in the degradation of the epidermal 
growth factor receptor (EGFR).  However as Gag binds to and hence depletes VPS23, the 
rate of EGFR down-regulation is reduced resulting in increased intracellular retention of 
EGFR.  This in turn allows for prolonged EGFR-mediated signaling through ERK/MAP 
kinase and hence cellular proliferation [144]. 
Indoleamine 2,3-dioxygenase 1 (IDO1): IDO1 in the connectivity map contains a heme-
prosthetic group in its center.  The iron is present in the ferric (Fe3+) form in the inactive 
state and as Fe2+ in the active state [145].  IDO1 catalyzes the degradation of the essential 
amino acid L-tryptophan to N-formyl-kynurenine by incorporating molecular oxygen or 
a superoxide anion [146].  Superoxides are produced in high quantities at sites of 
infection or inflammation and IDO1 is known to be involved during the innate immune 
response of the host [145].  It is therefore an immunosuppressive enzyme that results in 
the suppression of T cell proliferation through the catabolism of tryptophan [147].  The 
increased expression of IDO1 and its down-stream metabolites of kynurenine is 
associated with several central nervous system disorders, including AIDS dementia 
complex [146].  During HIV-1 infection, IDO1 is regulated through both GP120 and Vpr 
viral proteins, which possess antagonistic effects on the cellular expression of IDO1.  
GP120 interacts with the cell surface coreceptors chemokine (C-C motif) receptor 4 
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(CCR4) and CXCR5.  It then induces increased production of IDO mRNA levels 
resulting in loss of CD4+ T cell function [147]. Vpr, on the other hand, results in 
increased glucocorticoids and in turn it affects the gene expression of glucocorticoid-
regulated genes including the down-regulation of IDO1 [148].   
CYP51A1 Cholesterol is necessary for HIV-1’s entry into and budding out of the host 
cell.  Since Nef is highly expressed in the early stages of the replication cycle of HIV-1, it 
can help facilitate the viral entry into the cell.  Nef is believed to influence cholesterol 
production by increasing the expression of the cytochrome P450 51 (CYP51) gene in 
cDNA microarray tests in Jurkat cells [149]  CYP51 is responsible for the 14α 
demethylation of lanosterol, necessary for ersgosterol biosynthesis [150].  Like other 
cytochrome P450 family members, CYP51 contains a heme iron in its active site [151].  
Blockage of the ersgosterol biosynthesis results in impairments of the membrane 
integrity and the function of membrane-associated proteins [150].  
ALOX5: Arachidonate 5-lipoxygenase (ALOX5) is a nonheme iron-containing 
dioxygenase  that plays an important role in the biosynthesis of leukotrienes, namely the 
catalysis of the production of leukotriene LTA4 from arachidonic acid, which can then 
be converted to LTB4 [152].  Leukotrienes are important inflammatory mediators and 
LTB4 can then induce the adhesion and activation of leukocytes, ALOX5 is therefore 
mainly expressed in the different leukocytes [153].  Research by Maccarrone et al. [154, 
155] suggests that the HIV-1 coat glycoprotein GP120 enhances the activity of ALOX5 
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resulting in increased LTB4 production and consequent cell death in neuroblastoma 
cells.  In addition, ALOX5 might be capable of inducing cell cytotoxicity by oxidizing 
cellular membranes [154, 155].  Nonetheless, leukotriene synthesis is in fact reduced in 
the macrophages and peripheral mononuclear cells of HIV patients [156-158], although 
GP120 was not cited as the cause.   
Figure 11 is a bar graph comparing interaction types between all interactions in the HIV-
1 Human Interaction Database and those interactions that involve an iron binding 
protein. The graph suggests that HIV utilizes iron binding proteins more in regulatory 
alterations including up/down regulations or activation.  
 
Figure 11. Frequency of different types of HIV-1 interaction types 
The chart reflects percentage of top 10 interaction types between iron-binding proteins and HIV-1 
proteins (green bars) in compare with all interactions of HIV-1 proteins with human proteins 
(yellow bars) 
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Overall the map indicates loci of human protein networks important for HIV infection. 
The map would be strengthened by the identification of regions within it that are 
important for other viral infections. The set of proteins appearing in the map can be used 
to test how imposed changes on cells can alter iron ion binding protein network in gene 
set enrichment analysis through microarray experiments.  
4.4. Conclusions 
In this study, a connectivity map uncovering crosstalk between HIV and the iron ion 
mediated signaling and metabolism pathways of the host was developed.   This notation 
is detailed enough to summarize the research findings with accuracy. The connectivity 
map thus produced, when integrated with further network analysis, will guide 
researchers to the impact of viral infections on iron ion dependent processes in the host 
cell.    
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Chapter 5: Conclusions 
This doctoral thesis focused on the use of bioinformatics databases and tools in the 
discovery of the biological rules governing HIV-host protein interactions. For this 
purpose, we used protein-sequence data, large-scale data on human protein binding 
interactions, a database on HIV-1, Human Protein Interactions, along with extensive 
research literature. The bioinformatics tools utilized included statistical enrichment 
analysis, motif discovery methods, gene ontology and pathway analysis, network 
development tools, and code writing. This work is novel in the system level approach to 
motif discovery in combinations of host and viral proteins and interpreting the complex 
data resulting from this approach. The viral motif-host protein interactions presented in 
my thesis comprise important contributions to research literature on HIV-host crosstalk. 
In addition, through the use of iron-ion dependent host cell mechanisms, it has been 
illustrated how currently available network building techniques enable one to integrate 
patchy research literature into a portrayal of species crosstalk affecting modes of host 
protein networks.  
Motifs and hotspots discovered and annotated in Chapters 2 and 3 can be further 
studied by projecting them to available 3D structures of proteins and calculating their 
surface availability. Also co-operative binding of such hotspots can be verified by 
experimental methods. Emerging soft docking algorithms along with increasing 
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numbers of available protein structures in PDB will allow for the discovery of hotspots 
and motifs counterpart. 
Main conclusions reached in this thesis are as follows: 
 HIV virus proteins express sequential hotspots for interacting with host hub 
proteins. These hotspots intersect with multiple viral motifs indicating how 
diversity in virus-host proteins is achieved through the use of a finite set of 
sequence hotspots in crosstalk with the host. 
 HIV sequence hotspots predicted in the present study accurately produce much 
of the research literature on sites of binding events of HIV proteins.   
 Predictions presented in this thesis could be further studied by experimental 
approaches involving viral protein segments and site-directed mutagenesis 
experiments.  
 The study on HIV Nef presented in Chapter 3, uncovers motifs and hotspots 
potentially used by this virus protein to interact with nineteen host proteins.  
 The study presented in this dissertation, indicates the presence of multiple viral 
hotspots for binding to a given host protein, suggesting that motif-host protein 
combinations need to be considered as a dominant mode of interaction in virus-
host protein binding interactions.   
 This thesis exposes the many challenges of current motif discovery approaches in 
their application to the discovery of the grammar of crosstalk between species. 
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Current methods produce way too many motifs that could potentially be 
integrated without loss of specificity. The methods become more limited in their 
efficiency with increasing numbers of protein sequences for motif discovery.  
 Results presented in this dissertation, produce candidate sites for further 
experimental sites and provide rationale for developing high throughput 
experimental schemes for virus host binding experiments. 
 The study presented in this thesis is relevant to current treatments of HIV 
infection as it suggests viral sequence sites to be targeted by current and newly 
developing drug regiments. Moreover, the methodology developed in this thesis, 
can also be used to study other virus-host interactions. 
 In this work it was shown how network building techniques can be used to draw 
portrays of host-virus crosstalk. Illustrated in this case for HIV – iron ion binding 
proteins. 
 This thesis underscores the need for further development of bioinformatics tools 
for binding interface discovery including 3D docking simulations and molecular 
dynamics simulations.  
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Appendices 
Appendix A: List of motifs defining hotspots per HIV protein accessible at 
http://bioinformatics.biomed.drexel.edu/mahdi/ 
This file is a nine tab Excel spread sheet containing motifs shared by HIV proteins and 
some of the neighbors of HIV protein targeted hub proteins. Each tab lists motifs for an 
HIV protein with its corresponding details. Headings Hub ID and Hub Symbol represent 
the Entrez ID and gene symbol of the hub protein to which the motif belongs. Pattern is 
the regular expression of the motif. Info Content is the information content of the motif 
pattern. The p value is computed by statistical enrichment of the motif among neighbors 
of the hub protein in comparison to HPRD proteins. The number of neighbors of a hub 
protein and the neighbors on which the motif is present are shown with the symbols # of 
H2s and H2s w/Motif, respectively. Start and End headings refer to the start and end 
positions of the motif on the corresponding HIV protein sequence, calculated based on 
the most common positions observed on the HIV protein sequences. 
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